Pathway | Proteins | Compounds |
Glycolysis | 61 | 32 |
Transport of small molecules | 392 | 95 |
ABC-family proteins mediated transport | 77 | 11 |
ABC transporters in lipid homeostasis | 14 | 5 |
Mitochondrial ABC transporters | 4 | 6 |
SLC-mediated transmembrane transport | 135 | 67 |
Cellular hexose transport | 12 | 3 |
Transport of vitamins, nucleosides, and related molecules | 27 | 18 |
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | 10 | 4 |
Aquaporin-mediated transport | 18 | 11 |
Vasopressin regulates renal water homeostasis via Aquaporins | 9 | 9 |
Iron uptake and transport | 29 | 19 |
Transferrin endocytosis and recycling | 10 | 7 |
Ion channel transport | 45 | 16 |
Ion transport by P-type ATPases | 13 | 12 |
Stimuli-sensing channels | 29 | 10 |
Lipoprotein metabolism | 53 | 9 |
Plasma lipoprotein assembly | 16 | 8 |
HDL assembly | 5 | 8 |
Plasma lipoprotein remodeling | 25 | 6 |
HDL remodeling | 9 | 6 |
Mitophagy | 21 | 2 |
Receptor Mediated Mitophagy | 7 | 2 |
Vesicle-mediated transport | 333 | 16 |
Membrane Trafficking | 308 | 14 |
ER to Golgi Anterograde Transport | 63 | 6 |
COPII-mediated vesicle transport | 33 | 6 |
COPI-mediated anterograde transport | 31 | 5 |
Intra-Golgi and retrograde Golgi-to-ER traffic | 77 | 10 |
Retrograde transport at the Trans-Golgi-Network | 39 | 6 |
Intra-Golgi traffic | 24 | 5 |
Golgi-to-ER retrograde transport | 26 | 8 |
COPI-dependent Golgi-to-ER retrograde traffic | 19 | 4 |
COPI-independent Golgi-to-ER retrograde traffic | 7 | 7 |
trans-Golgi Network Vesicle Budding | 37 | 5 |
Golgi Associated Vesicle Biogenesis | 22 | 5 |
Lysosome Vesicle Biogenesis | 19 | 5 |
Gap junction trafficking and regulation | 9 | 2 |
Regulation of gap junction activity | 4 | 2 |
Clathrin-mediated endocytosis | 65 | 7 |
Cargo recognition for clathrin-mediated endocytosis | 37 | 3 |
Endosomal Sorting Complex Required For Transport (ESCRT) | 13 | 3 |
Translocation of SLC2A4 (GLUT4) to the plasma membrane | 45 | 9 |
Rab regulation of trafficking | 58 | 8 |
RAB GEFs exchange GTP for GDP on RABs | 37 | 4 |
Organelle biogenesis and maintenance | 232 | 16 |
Mitochondrial biogenesis | 66 | 8 |
Activation of PPARGC1A (PGC-1alpha) by phosphorylation | 2 | 3 |
Transcriptional activation of mitochondrial biogenesis | 35 | 7 |
Developmental Biology | 727 | 30 |
Axon guidance | 313 | 13 |
Semaphorin interactions | 40 | 7 |
Sema4D in semaphorin signaling | 10 | 7 |
Sema4D mediated inhibition of cell attachment and migration | 8 | 7 |
Sema4D induced cell migration and growth-cone collapse | 5 | 5 |
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 10 | 6 |
Sema3A PAK dependent Axon repulsion | 7 | 3 |
CRMPs in Sema3A signaling | 7 | 2 |
NCAM signaling for neurite out-growth | 16 | 5 |
NCAM1 interactions | 5 | 1 |
Netrin-1 signaling | 26 | 7 |
DCC mediated attractive signaling | 7 | 4 |
Netrin mediated repulsion signals | 5 | 2 |
Role of second messengers in netrin-1 signaling | 5 | 4 |
DSCAM interactions | 6 | 4 |
Signaling by ROBO receptors | 163 | 7 |
Regulation of commissural axon pathfinding by SLIT and ROBO | 6 | 2 |
Role of ABL in ROBO-SLIT signaling | 2 | 2 |
ROBO receptors bind AKAP5 | 6 | 2 |
L1CAM interactions | 54 | 7 |
Recycling pathway of L1 | 12 | 5 |
Interaction between L1 and Ankyrins | 3 | 2 |
Signal transduction by L1 | 19 | 4 |
Neurofascin interactions | 7 | 2 |
EPH-Ephrin signaling | 38 | 9 |
EPHA-mediated growth cone collapse | 3 | 4 |
EPHB-mediated forward signaling | 24 | 9 |
Ephrin signaling | 6 | 4 |
EPH-ephrin mediated repulsion of cells | 9 | 4 |
RET signaling | 13 | 2 |
Reelin signalling pathway | 5 | 2 |
Myogenesis | 10 | 3 |
Regulation of beta-cell development | 29 | 2 |
Regulation of gene expression in beta cells | 17 | 2 |
AKT-mediated inactivation of FOXO1A | 1 | 2 |
Signaling by NODAL | 13 | 2 |
Cell-Cell communication | 79 | 3 |
Signal regulatory protein family interactions | 9 | 2 |
Nephrin family interactions | 7 | 2 |
Hemostasis | 239 | 44 |
Platelet homeostasis | 18 | 27 |
Platelet calcium homeostasis | 5 | 5 |
Elevation of cytosolic Ca2+ levels | 3 | 3 |
Platelet sensitization by LDL | 8 | 3 |
Platelet activation, signaling and aggregation | 63 | 15 |
Signal amplification | 8 | 6 |
ADP signalling through P2Y purinoceptor 1 | 4 | 5 |
GPVI-mediated activation cascade | 17 | 5 |
Platelet Aggregation (Plug Formation) | 21 | 7 |
Integrin signaling | 15 | 7 |
p130Cas linkage to MAPK signaling for integrins | 3 | 2 |
Effects of PIP2 hydrolysis | 1 | 10 |
Response to elevated platelet cytosolic Ca2+ | 8 | 6 |
Disinhibition of SNARE formation | 5 | 3 |
Platelet degranulation | 3 | 5 |
Cell surface interactions at the vascular wall | 80 | 7 |
Tie2 Signaling | 11 | 4 |
PECAM1 interactions | 7 | 2 |
Factors involved in megakaryocyte development and platelet production | 50 | 15 |
Kinesins | 15 | 2 |
Reproduction | 86 | 8 |
Meiosis | 59 | 4 |
Meiotic synapsis | 34 | 2 |
Metabolism | 1496 | 1108 |
Carbohydrate metabolism | 173 | 120 |
Glycogen metabolism | 20 | 16 |
Glycogen breakdown (glycogenolysis) | 13 | 11 |
Glucose metabolism | 76 | 42 |
Gluconeogenesis | 30 | 31 |
Fructose metabolism | 7 | 21 |
Fructose catabolism | 5 | 15 |
Galactose catabolism | 4 | 10 |
Pentose phosphate pathway | 13 | 30 |
PRPP biosynthesis | 3 | 8 |
Glycosaminoglycan metabolism | 36 | 37 |
Transport and synthesis of PAPS | 0 | 7 |
Formation of xylulose-5-phosphate | 5 | 15 |
Inositol phosphate metabolism | 32 | 35 |
Synthesis of IP3 and IP4 in the cytosol | 20 | 11 |
Synthesis of IPs in the nucleus | 2 | 14 |
Synthesis of pyrophosphates in the cytosol | 6 | 15 |
Metabolism of lipids | 500 | 463 |
Fatty acid metabolism | 113 | 203 |
Fatty acyl-CoA biosynthesis | 16 | 35 |
Synthesis of very long-chain fatty acyl-CoAs | 3 | 23 |
Arachidonic acid metabolism | 36 | 82 |
Synthesis of Leukotrienes (LT) and Eoxins (EX) | 13 | 29 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 10 | 41 |
alpha-linolenic acid (ALA) metabolism | 10 | 31 |
Linoleic acid (LA) metabolism | 5 | 24 |
Carnitine metabolism | 10 | 13 |
Mitochondrial Fatty Acid Beta-Oxidation | 22 | 60 |
mitochondrial fatty acid beta-oxidation of saturated fatty acids | 9 | 42 |
Beta oxidation of butanoyl-CoA to acetyl-CoA | 3 | 14 |
Propionyl-CoA catabolism | 3 | 9 |
Peroxisomal lipid metabolism | 25 | 52 |
Alpha-oxidation of phytanate | 6 | 25 |
Triglyceride metabolism | 13 | 17 |
Triglyceride biosynthesis | 3 | 10 |
Triglyceride catabolism | 10 | 13 |
Phospholipid metabolism | 122 | 42 |
Glycerophospholipid biosynthesis | 74 | 39 |
Synthesis of PE | 9 | 14 |
Synthesis of PC | 20 | 17 |
PI Metabolism | 49 | 11 |
Synthesis of PIPs at the ER membrane | 3 | 4 |
Synthesis of PIPs at the Golgi membrane | 8 | 5 |
Synthesis of PIPs at the plasma membrane | 27 | 5 |
Synthesis of PIPs at the early endosome membrane | 9 | 4 |
Synthesis of PIPs at the late endosome membrane | 6 | 4 |
Synthesis of PIPs in the nucleus | 4 | 4 |
Sphingolipid metabolism | 55 | 50 |
Sphingolipid de novo biosynthesis | 17 | 16 |
Glycosphingolipid metabolism | 30 | 31 |
Metabolism of steroids | 111 | 135 |
Cholesterol biosynthesis | 22 | 49 |
Bile acid and bile salt metabolism | 31 | 71 |
Synthesis of bile acids and bile salts | 20 | 68 |
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 16 | 44 |
Synthesis of bile acids and bile salts via 24-hydroxycholesterol | 8 | 31 |
Recycling of bile acids and salts | 18 | 10 |
Ketone body metabolism | 10 | 19 |
Synthesis of Ketone Bodies | 8 | 17 |
Integration of energy metabolism | 49 | 27 |
Regulation of insulin secretion | 30 | 19 |
Acetylcholine regulates insulin secretion | 3 | 8 |
Free fatty acids regulate insulin secretion | 2 | 11 |
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 9 | 7 |
Glucagon signaling in metabolic regulation | 2 | 6 |
PKA activation in glucagon signalling | 0 | 5 |
PKA-mediated phosphorylation of key metabolic factors | 2 | 2 |
AMPK inhibits chREBP transcriptional activation activity | 8 | 3 |
Metabolism of nitric oxide: NOS3 activation and regulation | 14 | 26 |
eNOS activation | 10 | 26 |
The citric acid (TCA) cycle and respiratory electron transport | 147 | 56 |
Pyruvate metabolism and Citric Acid (TCA) cycle | 41 | 46 |
Pyruvate metabolism | 20 | 26 |
Regulation of pyruvate dehydrogenase (PDH) complex | 9 | 14 |
Citric acid cycle (TCA cycle) | 18 | 27 |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 110 | 19 |
Formation of ATP by chemiosmotic coupling | 18 | 5 |
Nucleotide metabolism | 89 | 125 |
Nucleotide biosynthesis | 12 | 46 |
Purine ribonucleoside monophosphate biosynthesis | 9 | 36 |
Pyrimidine biosynthesis | 3 | 21 |
Interconversion of nucleotide di- and triphosphates | 22 | 30 |
Nucleotide salvage | 21 | 28 |
Purine salvage | 13 | 22 |
Pyrimidine salvage | 9 | 13 |
Metabolism of vitamins and cofactors | 146 | 155 |
Metabolism of water-soluble vitamins and cofactors | 102 | 114 |
Vitamin B1 (thiamin) metabolism | 3 | 9 |
Vitamin B2 (riboflavin) metabolism | 4 | 11 |
Vitamin B5 (pantothenate) metabolism | 16 | 20 |
Coenzyme A biosynthesis | 5 | 14 |
Vitamin B6 activation to pyridoxal phosphate | 3 | 18 |
Cobalamin (Cbl, vitamin B12) transport and metabolism | 18 | 25 |
Biotin transport and metabolism | 11 | 8 |
Nicotinate metabolism | 22 | 43 |
Nicotinamide salvaging | 10 | 30 |
Metabolism of folate and pterines | 16 | 29 |
Molybdenum cofactor biosynthesis | 8 | 17 |
Metabolism of cofactors | 19 | 47 |
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | 10 | 25 |
Amino acid and derivative metabolism | 250 | 260 |
Serine biosynthesis | 4 | 16 |
Branched-chain amino acid catabolism | 20 | 31 |
Histidine catabolism | 8 | 22 |
Creatine metabolism | 6 | 15 |
Urea cycle | 8 | 22 |
Sulfur amino acid metabolism | 27 | 63 |
Selenoamino acid metabolism | 24 | 50 |
Metabolism of ingested SeMet, Sec, MeSec into H2Se | 4 | 23 |
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | 2 | 18 |
Selenocysteine synthesis | 6 | 14 |
Threonine catabolism | 5 | 14 |
Porphyrin metabolism | 23 | 44 |
Heme biosynthesis | 15 | 30 |
Heme degradation | 10 | 21 |
Biological oxidations | 150 | 276 |
Phase I - Functionalization of compounds | 69 | 175 |
Ethanol oxidation | 12 | 16 |
Phase II - Conjugation of compounds | 73 | 122 |
Cytosolic sulfonation of small molecules | 17 | 47 |
Methylation | 13 | 38 |
Glutathione conjugation | 35 | 23 |
Glutathione synthesis and recycling | 11 | 14 |
Amino Acid conjugation | 0 | 15 |
Conjugation of carboxylic acids | 0 | 15 |
Conjugation of benzoate with glycine | 0 | 8 |
Conjugation of phenylacetate with glutamine | 0 | 8 |
Conjugation of salicylate with glycine | 0 | 8 |
Abacavir ADME | 6 | 24 |
Abacavir transmembrane transport | 2 | 5 |
Abacavir metabolism | 4 | 23 |
Programmed Cell Death | 170 | 12 |
Apoptosis | 147 | 5 |
Caspase activation via extrinsic apoptotic signalling pathway | 15 | 2 |
Ligand-independent caspase activation via DCC | 7 | 2 |
Intrinsic Pathway for Apoptosis | 46 | 4 |
Activation of BH3-only proteins | 21 | 4 |
Activation of BAD and translocation to mitochondria | 12 | 4 |
Activation of BIM and translocation to mitochondria | 3 | 2 |
Activation of BMF and translocation to mitochondria | 3 | 2 |
Apoptotic factor-mediated response | 20 | 2 |
Cytochrome c-mediated apoptotic response | 13 | 2 |
Formation of apoptosome | 11 | 2 |
Activation of caspases through apoptosome-mediated cleavage | 6 | 2 |
Apoptotic execution phase | 44 | 2 |
Stimulation of the cell death response by PAK-2p34 | 2 | 2 |
Regulated Necrosis | 38 | 9 |
RIPK1-mediated regulated necrosis | 23 | 7 |
Regulation of necroptotic cell death | 21 | 6 |
DNA Repair | 255 | 47 |
DNA Damage Bypass | 41 | 7 |
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | 35 | 7 |
Translesion Synthesis by POLH | 6 | 4 |
DNA Double-Strand Break Repair | 103 | 13 |
DNA Double Strand Break Response | 37 | 9 |
Sensing of DNA Double Strand Breaks | 6 | 4 |
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 33 | 7 |
Homology Directed Repair | 83 | 9 |
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 79 | 9 |
Processing of DNA double-strand break ends | 51 | 8 |
HDR through Homologous Recombination (HRR) | 48 | 5 |
Homologous DNA Pairing and Strand Exchange | 31 | 2 |
Presynaptic phase of homologous DNA pairing and strand exchange | 25 | 2 |
Resolution of D-Loop Structures | 33 | 4 |
Resolution of D-loop Structures through Holliday Junction Intermediates | 32 | 4 |
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 23 | 4 |
HDR through Single Strand Annealing (SSA) | 31 | 2 |
Nonhomologous End-Joining (NHEJ) | 33 | 4 |
Nucleotide Excision Repair | 84 | 7 |
Global Genome Nucleotide Excision Repair (GG-NER) | 58 | 7 |
Formation of Incision Complex in GG-NER | 29 | 4 |
Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 58 | 5 |
Dual incision in TC-NER | 47 | 3 |
MMR | 15 | 8 |
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 14 | 8 |
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 14 | 8 |
Fanconi Anemia Pathway | 29 | 4 |
Signaling Pathways | 1269 | 117 |
Signaling by Receptor Tyrosine Kinases | 293 | 35 |
Signaling by EGFR | 29 | 7 |
EGFR interacts with phospholipase C-gamma | 2 | 2 |
SHC1 events in EGFR signaling | 4 | 4 |
GAB1 signalosome | 10 | 4 |
EGFR downregulation | 15 | 5 |
Signaling by FGFR | 47 | 7 |
Signaling by FGFR1 | 27 | 5 |
FGFR1 ligand binding and activation | 7 | 2 |
FGFR1b ligand binding and activation | 4 | 2 |
FGFR1c ligand binding and activation | 5 | 2 |
FGFR1c and Klotho ligand binding and activation | 2 | 2 |
Downstream signaling of activated FGFR1 | 10 | 4 |
FRS-mediated FGFR1 signaling | 6 | 4 |
Phospholipase C-mediated cascade: FGFR1 | 2 | 2 |
SHC-mediated cascade:FGFR1 | 3 | 4 |
PI-3K cascade:FGFR1 | 6 | 2 |
Negative regulation of FGFR1 signaling | 13 | 3 |
Spry regulation of FGF signaling | 10 | 3 |
Signaling by FGFR2 | 31 | 5 |
FGFR2 ligand binding and activation | 4 | 2 |
FGFR2b ligand binding and activation | 2 | 2 |
FGFR2c ligand binding and activation | 2 | 2 |
Downstream signaling of activated FGFR2 | 9 | 4 |
FRS-mediated FGFR2 signaling | 5 | 4 |
Phospholipase C-mediated cascade; FGFR2 | 1 | 2 |
SHC-mediated cascade:FGFR2 | 2 | 4 |
PI-3K cascade:FGFR2 | 6 | 2 |
Negative regulation of FGFR2 signaling | 11 | 3 |
Signaling by FGFR3 | 21 | 7 |
FGFR3 ligand binding and activation | 4 | 4 |
FGFR3b ligand binding and activation | 1 | 2 |
FGFR3c ligand binding and activation | 3 | 4 |
Downstream signaling of activated FGFR3 | 11 | 4 |
FRS-mediated FGFR3 signaling | 7 | 4 |
Phospholipase C-mediated cascade; FGFR3 | 3 | 2 |
SHC-mediated cascade:FGFR3 | 4 | 4 |
PI-3K cascade:FGFR3 | 6 | 2 |
Negative regulation of FGFR3 signaling | 11 | 3 |
Signaling by FGFR4 | 20 | 5 |
FGFR4 ligand binding and activation | 3 | 2 |
betaKlotho-mediated ligand binding | 3 | 2 |
Downstream signaling of activated FGFR4 | 12 | 4 |
FRS-mediated FGFR4 signaling | 8 | 4 |
Phospholipase C-mediated cascade; FGFR4 | 4 | 2 |
SHC-mediated cascade:FGFR4 | 5 | 4 |
PI-3K cascade:FGFR4 | 6 | 2 |
Negative regulation of FGFR4 signaling | 11 | 3 |
Signaling by NTRKs | 85 | 10 |
Signaling by NTRK1 (TRKA) | 66 | 9 |
Activation of TRKA receptors | 6 | 3 |
TRKA activation by NGF | 3 | 2 |
NGF-independant TRKA activation | 3 | 3 |
Signalling to ERKs | 21 | 6 |
Signalling to RAS | 8 | 5 |
p38MAPK events | 4 | 5 |
Prolonged ERK activation events | 15 | 5 |
Frs2-mediated activation | 12 | 5 |
ARMS-mediated activation | 7 | 5 |
PLC-gamma1 signalling | 3 | 2 |
PI3K/AKT activation | 3 | 2 |
Signalling to STAT3 | 3 | 2 |
Signalling to ERK5 | 2 | 2 |
Nuclear Events (kinase and transcription factor activation) | 33 | 4 |
ERK/MAPK targets | 8 | 4 |
CREB phosphorylation | 4 | 2 |
Signaling by NTRK2 (TRKB) | 20 | 4 |
BDNF activates NTRK2 (TRKB) signaling | 2 | 2 |
NTF3 activates NTRK2 (TRKB) signaling | 2 | 2 |
NTF4 activates NTRK2 (TRKB) signaling | 2 | 2 |
Activated NTRK2 signals through RAS | 3 | 4 |
Activated NTRK2 signals through PLCG1 | 2 | 2 |
Activated NTRK2 signals through PI3K | 5 | 2 |
Activated NTRK2 signals through FRS2 and FRS3 | 6 | 4 |
Activated NTRK2 signals through FYN | 5 | 4 |
Activated NTRK2 signals through CDK5 | 5 | 4 |
Signaling by NTRK3 (TRKC) | 11 | 6 |
NTF3 activates NTRK3 signaling | 2 | 2 |
Activated NTRK3 signals through PLCG1 | 3 | 2 |
Activated NTRK3 signals through RAS | 4 | 4 |
Activated NTRK3 signals through PI3K | 6 | 2 |
Signaling by Insulin receptor | 16 | 9 |
Insulin receptor signalling cascade | 10 | 8 |
IRS activation | 3 | 2 |
IRS-mediated signalling | 6 | 7 |
PI3K Cascade | 4 | 5 |
Activation of PKB | 2 | 2 |
PKB-mediated events | 2 | 5 |
PDE3B signalling | 2 | 5 |
Signal attenuation | 6 | 3 |
Signaling by PDGF | 17 | 6 |
Downstream signal transduction | 10 | 4 |
Signaling by VEGF | 62 | 25 |
VEGFA-VEGFR2 Pathway | 52 | 25 |
VEGFR2 mediated vascular permeability | 20 | 16 |
VEGFR2 mediated cell proliferation | 9 | 8 |
Signaling by SCF-KIT | 18 | 4 |
Regulation of KIT signaling | 9 | 2 |
Signaling by ERBB2 | 30 | 7 |
SHC1 events in ERBB2 signaling | 7 | 5 |
PI3K events in ERBB2 signaling | 5 | 2 |
PLCG1 events in ERBB2 signaling | 2 | 2 |
ERBB2 Activates PTK6 Signaling | 1 | 2 |
Downregulation of ERBB2 signaling | 12 | 4 |
Downregulation of ERBB2:ERBB3 signaling | 4 | 2 |
Signaling by ERBB4 | 33 | 6 |
SHC1 events in ERBB4 signaling | 3 | 4 |
PI3K events in ERBB4 signaling | 2 | 2 |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 9 | 7 |
IGF1R signaling cascade | 8 | 7 |
SHC-related events triggered by IGF1R | 3 | 4 |
IRS-related events triggered by IGF1R | 8 | 7 |
Signaling by MET | 32 | 6 |
MET Receptor Activation | 5 | 3 |
MET activates RAS signaling | 7 | 4 |
MET activates PI3K/AKT signaling | 5 | 2 |
MET promotes cell motility | 10 | 4 |
MET activates PTK2 signaling | 3 | 2 |
MET activates STAT3 | 2 | 2 |
Negative regulation of MET activity | 8 | 4 |
Signaling by MST1 | 3 | 3 |
Signaling by TGFB family members | 84 | 7 |
Signaling by TGF-beta Receptor Complex | 67 | 7 |
TGF-beta receptor signaling activates SMADs | 35 | 4 |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 12 | 3 |
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 32 | 6 |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 23 | 2 |
Downregulation of SMAD2/3:SMAD4 transcriptional activity | 17 | 6 |
Signaling by BMP | 11 | 2 |
Signaling by Activin | 15 | 2 |
Signaling by GPCR | 249 | 55 |
GPCR ligand binding | 193 | 39 |
Class A/1 (Rhodopsin-like receptors) | 161 | 36 |
Nucleotide-like (purinergic) receptors | 12 | 7 |
P2Y receptors | 12 | 6 |
GPCR downstream signalling | 172 | 52 |
G alpha (s) signalling events | 10 | 11 |
Olfactory Signaling Pathway | 80 | 28 |
G alpha (i) signalling events | 87 | 41 |
Opioid Signalling | 23 | 19 |
G-protein mediated events | 16 | 15 |
PLC beta mediated events | 15 | 14 |
Ca-dependent events | 14 | 9 |
phospho-PLA2 pathway | 2 | 5 |
CaM pathway | 12 | 8 |
Calmodulin induced events | 12 | 8 |
PKA-mediated phosphorylation of CREB | 4 | 6 |
PKA activation | 3 | 5 |
CaMK IV-mediated phosphorylation of CREB | 6 | 3 |
Adenylate cyclase activating pathway | 1 | 7 |
DARPP-32 events | 7 | 11 |
Visual phototransduction | 62 | 41 |
The canonical retinoid cycle in rods (twilight vision) | 14 | 15 |
The phototransduction cascade | 26 | 21 |
Inactivation, recovery and regulation of the phototransduction cascade | 25 | 18 |
G alpha (z) signalling events | 1 | 9 |
G alpha (q) signalling events | 79 | 28 |
Gastrin-CREB signalling pathway via PKC and MAPK | 12 | 4 |
G-protein beta:gamma signalling | 7 | 4 |
G beta:gamma signalling through PI3Kgamma | 3 | 2 |
Signaling by NOTCH | 113 | 14 |
Pre-NOTCH Expression and Processing | 24 | 13 |
Pre-NOTCH Transcription and Translation | 17 | 4 |
Signaling by NOTCH1 | 26 | 3 |
NOTCH1 Intracellular Domain Regulates Transcription | 15 | 2 |
Signaling by NOTCH3 | 29 | 3 |
NOTCH3 Activation and Transmission of Signal to the Nucleus | 13 | 3 |
Signaling by NOTCH4 | 65 | 3 |
Negative regulation of NOTCH4 signaling | 49 | 2 |
Signaling by WNT | 148 | 20 |
Degradation of beta-catenin by the destruction complex | 62 | 2 |
Beta-catenin phosphorylation cascade | 6 | 2 |
TCF dependent signaling in response to WNT | 104 | 9 |
WNT mediated activation of DVL | 3 | 2 |
Disassembly of the destruction complex and recruitment of AXIN to the membrane | 11 | 2 |
Deactivation of the beta-catenin transactivating complex | 19 | 2 |
Beta-catenin independent WNT signaling | 81 | 13 |
PCP/CE pathway | 66 | 5 |
Asymmetric localization of PCP proteins | 52 | 2 |
WNT5A-dependent internalization of FZD4 | 11 | 3 |
Ca2+ pathway | 16 | 12 |
Signaling by Hippo | 15 | 2 |
Signaling by Hedgehog | 93 | 11 |
Hedgehog ligand biogenesis | 56 | 7 |
Hedgehog 'off' state | 67 | 6 |
GLI3 is processed to GLI3R by the proteasome | 53 | 2 |
Degradation of GLI2 by the proteasome | 53 | 2 |
Degradation of GLI1 by the proteasome | 53 | 2 |
Hedgehog 'on' state | 70 | 2 |
Activation of SMO | 13 | 2 |
Signaling by Leptin | 7 | 2 |
Signaling by Nuclear Receptors | 152 | 46 |
Signaling by Retinoic Acid | 24 | 31 |
ESR-mediated signaling | 102 | 23 |
Estrogen-dependent gene expression | 80 | 4 |
MAPK family signaling cascades | 115 | 19 |
ERK1/ERK2 pathway | 93 | 19 |
RAF/MAP kinase cascade | 91 | 19 |
RAF activation | 8 | 5 |
MAP2K and MAPK activation | 9 | 3 |
Negative regulation of MAPK pathway | 16 | 5 |
Negative feedback regulation of MAPK pathway | 4 | 2 |
RAF-independent MAPK1/3 activation | 7 | 4 |
MAPK3 (ERK1) activation | 4 | 2 |
MAPK1 (ERK2) activation | 3 | 2 |
MAPK6/MAPK4 signaling | 68 | 5 |
Intracellular signaling by second messengers | 126 | 14 |
PI3K/AKT Signaling | 113 | 8 |
AKT phosphorylates targets in the cytosol | 7 | 2 |
AKT phosphorylates targets in the nucleus | 3 | 2 |
Negative regulation of the PI3K/AKT network | 18 | 5 |
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 17 | 4 |
PTEN Regulation | 77 | 6 |
Regulation of PTEN gene transcription | 22 | 3 |
Regulation of PTEN stability and activity | 52 | 5 |
DAG and IP3 signaling | 14 | 10 |
Signaling by Rho GTPases | 181 | 20 |
Rho GTPase cycle | 4 | 6 |
RHO GTPase Effectors | 166 | 20 |
RHO GTPases Activate ROCKs | 6 | 5 |
RHO GTPases activate PAKs | 15 | 6 |
RHO GTPases activate PKNs | 21 | 10 |
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | 6 | 7 |
RHO GTPases activate CIT | 14 | 3 |
RHO GTPases Activate WASPs and WAVEs | 17 | 3 |
RHO GTPases Activate Formins | 83 | 7 |
RHO GTPases Activate NADPH Oxidases | 18 | 12 |
Signaling by Non-Receptor Tyrosine Kinases | 31 | 6 |
Signaling by PTK6 | 31 | 6 |
PTK6 Activates STAT3 | 4 | 2 |
PTK6 Regulates Cell Cycle | 2 | 2 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 9 | 5 |
PTK6 Regulates Proteins Involved in RNA Processing | 5 | 2 |
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | 5 | 2 |
PTK6 promotes HIF1A stabilization | 6 | 2 |
PTK6 Down-Regulation | 3 | 4 |
MTOR signalling | 30 | 8 |
Inhibition of TSC complex formation by PKB | 3 | 2 |
mTORC1-mediated signalling | 11 | 3 |
Energy dependent regulation of mTOR by LKB1-AMPK | 5 | 7 |
Death Receptor Signaling | 75 | 9 |
TNF signaling | 37 | 3 |
Regulation of TNFR1 signaling | 32 | 2 |
p75 NTR receptor-mediated signalling | 32 | 9 |
Cell death signalling via NRAGE, NRIF and NADE | 15 | 5 |
NRAGE signals death through JNK | 8 | 5 |
NRIF signals cell death from the nucleus | 8 | 2 |
p75NTR signals via NF-kB | 13 | 2 |
p75NTR recruits signalling complexes | 10 | 2 |
NF-kB is activated and signals survival | 8 | 2 |
Signaling by Erythropoietin | 18 | 6 |
Erythropoietin activates STAT5 | 5 | 2 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 12 | 2 |
Erythropoietin activates RAS | 11 | 4 |
Erythropoietin activates Phospholipase C gamma (PLCG) | 5 | 4 |
Cellular responses to stimuli | 483 | 56 |
Macroautophagy | 56 | 7 |
Cellular responses to stress | 469 | 54 |
Detoxification of Reactive Oxygen Species | 30 | 27 |
Cellular response to heat stress | 70 | 9 |
HSF1-dependent transactivation | 9 | 4 |
Regulation of HSF1-mediated heat shock response | 57 | 7 |
Cellular Senescence | 84 | 9 |
Oncogene Induced Senescence | 14 | 2 |
Oxidative Stress Induced Senescence | 25 | 7 |
DNA Damage/Telomere Stress Induced Senescence | 25 | 4 |
Senescence-Associated Secretory Phenotype (SASP) | 37 | 4 |
HSP90 chaperone cycle for SHRs | 14 | 5 |
Muscle contraction | 77 | 21 |
Striated Muscle Contraction | 6 | 4 |
Smooth Muscle Contraction | 20 | 15 |
Cardiac conduction | 52 | 12 |
Ion homeostasis | 18 | 10 |
Neuronal System | 166 | 50 |
Transmission across Chemical Synapses | 122 | 50 |
Neurotransmitter release cycle | 31 | 33 |
Norepinephrine Neurotransmitter Release Cycle | 12 | 12 |
Serotonin Neurotransmitter Release Cycle | 11 | 5 |
Dopamine Neurotransmitter Release Cycle | 13 | 5 |
Acetylcholine Neurotransmitter Release Cycle | 13 | 9 |
Neurotransmitter uptake and metabolism In glial cells | 2 | 6 |
Astrocytic Glutamate-Glutamine Uptake And Metabolism | 2 | 6 |
Neurotransmitter receptors and postsynaptic signal transmission | 78 | 20 |
Glutamate binding, activation of AMPA receptors and synaptic plasticity | 17 | 6 |
Trafficking of AMPA receptors | 17 | 4 |
Trafficking of GluR2-containing AMPA receptors | 11 | 4 |
Activation of NMDA receptors and postsynaptic events | 40 | 13 |
Post NMDA receptor activation events | 22 | 8 |
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 8 | 6 |
RSK activation | 3 | 2 |
CREB1 phosphorylation through the activation of Adenylate Cyclase | 2 | 5 |
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | 6 | 3 |
Potassium Channels | 24 | 4 |
Inwardly rectifying K+ channels | 9 | 3 |
ATP sensitive Potassium channels | 2 | 2 |
Cell Cycle | 538 | 31 |
Cell Cycle Checkpoints | 173 | 2 |
G1/S DNA Damage Checkpoints | 59 | 2 |
p53-Dependent G1/S DNA damage checkpoint | 57 | 2 |
p53-Dependent G1 DNA Damage Response | 57 | 2 |
Stabilization of p53 | 53 | 2 |
Autodegradation of the E3 ubiquitin ligase COP1 | 48 | 2 |
p53-Independent G1/S DNA damage checkpoint | 48 | 2 |
p53-Independent DNA Damage Response | 48 | 2 |
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | 48 | 2 |
G2/M Checkpoints | 84 | 2 |
G2/M DNA damage checkpoint | 31 | 2 |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 13 | 2 |
G2/M DNA replication checkpoint | 4 | 2 |
Activation of ATR in response to replication stress | 17 | 2 |
Cell Cycle, Mitotic | 410 | 31 |
Mitotic G1 phase and G1/S transition | 118 | 4 |
G0 and Early G1 | 21 | 2 |
G1 Phase | 17 | 4 |
Cyclin D associated events in G1 | 17 | 4 |
G1/S Transition | 100 | 4 |
Cyclin E associated events during G1/S transition | 60 | 4 |
SCF(Skp2)-mediated degradation of p27/p21 | 49 | 2 |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | 2 | 2 |
Activation of the pre-replicative complex | 22 | 3 |
S Phase | 131 | 14 |
Cyclin A:Cdk2-associated events at S phase entry | 59 | 4 |
Synthesis of DNA | 113 | 10 |
Switching of origins to a post-replicative state | 84 | 2 |
Orc1 removal from chromatin | 59 | 2 |
CDK-mediated phosphorylation and removal of Cdc6 | 65 | 2 |
DNA strand elongation | 25 | 6 |
Leading Strand Synthesis | 10 | 2 |
Polymerase switching | 10 | 2 |
Lagging Strand Synthesis | 16 | 6 |
Ubiquitin-dependent degradation of Cyclin D | 48 | 2 |
Mitotic G2-G2/M phases | 173 | 8 |
G2 Phase | 1 | 2 |
G2/M Transition | 172 | 8 |
Cyclin A/B1/B2 associated events during G2/M transition | 18 | 7 |
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes | 3 | 2 |
Regulation of PLK1 Activity at G2/M Transition | 75 | 5 |
Polo-like kinase mediated events | 16 | 2 |
Centrosome maturation | 79 | 2 |
Loss of proteins required for interphase microtubule organization from the centrosome | 69 | 2 |
Loss of Nlp from mitotic centrosomes | 69 | 2 |
The role of GTSE1 in G2/M progression after G2 checkpoint | 53 | 2 |
AURKA Activation by TPX2 | 64 | 2 |
Interaction between PHLDA1 and AURKA | 2 | 2 |
M Phase | 279 | 21 |
Mitotic Prophase | 62 | 14 |
Golgi Cisternae Pericentriolar Stack Reorganization | 12 | 3 |
Condensation of Prophase Chromosomes | 13 | 10 |
MASTL Facilitates Mitotic Progression | 6 | 2 |
Nuclear Envelope Breakdown | 39 | 5 |
Activation of NIMA Kinases NEK9, NEK6, NEK7 | 5 | 2 |
Nuclear Pore Complex (NPC) Disassembly | 32 | 2 |
Depolymerization of the Nuclear Lamina | 7 | 5 |
Mitotic Prometaphase | 142 | 6 |
Resolution of Sister Chromatid Cohesion | 47 | 6 |
Condensation of Prometaphase Chromosomes | 9 | 4 |
Mitotic Metaphase and Anaphase | 158 | 12 |
FOXO-mediated transcription | 60 | 7 |
Regulation of localization of FOXO transcription factors | 8 | 2 |
Extra-nuclear estrogen signaling | 27 | 20 |
Estrogen-stimulated signaling through PRKCZ | 3 | 4 |
Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 14 | 2 |
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 5 | 6 |
Intracellular metabolism of fatty acids regulates insulin secretion | 1 | 6 |
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 7 | 3 |
Assembly and cell surface presentation of NMDA receptors | 17 | 3 |
Long-term potentiation | 6 | 4 |
Activation of RAC1 downstream of NMDARs | 5 | 5 |
Activation of AMPK downstream of NMDARs | 3 | 3 |
Regulation of the apoptosome activity | 11 | 2 |
Mitotic Metaphase/Anaphase Transition | 2 | 2 |
Mitotic Anaphase | 157 | 12 |
Regulatory network of nutrient accumulation | 10 | 11 |
Regulation of leaf development | 17 | 22 |
Response to Drought | 5 | 4 |
HSFA7/ HSFA6B-regulatory network-induced by drought and ABA. | 3 | 4 |
Response to salinity | 4 | 4 |
Nuclear Envelope (NE) Reassembly | 51 | 10 |
Initiation of Nuclear Envelope (NE) Reformation | 14 | 7 |
cell division | 11 | 2 |
Regulation of mitotic cell cycle | 79 | 4 |
APC/C-mediated degradation of cell cycle proteins | 79 | 4 |
Regulation of APC/C activators between G1/S and early anaphase | 75 | 2 |
Phosphorylation of Emi1 | 4 | 2 |
Chromosome Maintenance | 92 | 13 |
Telomere Maintenance | 65 | 13 |
Extension of Telomeres | 46 | 13 |
Telomere Extension By Telomerase | 19 | 9 |
Telomere C-strand (Lagging Strand) Synthesis | 31 | 13 |
Polymerase switching on the C-strand of the telomere | 24 | 4 |
Processive synthesis on the C-strand of the telomere | 16 | 13 |
Metabolism of proteins | 1058 | 144 |
Translation | 267 | 33 |
tRNA Aminoacylation | 42 | 26 |
Cytosolic tRNA aminoacylation | 24 | 26 |
Mitochondrial tRNA aminoacylation | 21 | 26 |
Eukaryotic Translation Initiation | 103 | 5 |
Cap-dependent Translation Initiation | 103 | 5 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 52 | 3 |
Ribosomal scanning and start codon recognition | 9 | 3 |
L13a-mediated translational silencing of Ceruloplasmin expression | 47 | 2 |
Protein folding | 24 | 4 |
Chaperonin-mediated protein folding | 18 | 4 |
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 14 | 4 |
Formation of tubulin folding intermediates by CCT/TriC | 7 | 4 |
Folding of actin by CCT/TriC | 8 | 3 |
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 10 | 3 |
Post-translational protein modification | 666 | 112 |
Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | 46 | 26 |
Synthesis of diphthamide-EEF2 | 8 | 7 |
Asparagine N-linked glycosylation | 164 | 78 |
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 50 | 68 |
Synthesis of substrates in N-glycan biosythesis | 37 | 56 |
Synthesis of Dolichyl-phosphate | 6 | 17 |
Synthesis of UDP-N-acetyl-glucosamine | 6 | 17 |
Sialic acid metabolism | 13 | 18 |
GDP-fucose biosynthesis | 6 | 16 |
Transport to the Golgi and subsequent modification | 85 | 18 |
O-linked glycosylation | 19 | 19 |
SUMOylation | 167 | 6 |
Processing and activation of SUMO | 7 | 3 |
SUMO is conjugated to E1 (UBA2:SAE1) | 5 | 3 |
Deubiquitination | 150 | 4 |
Ovarian tumor domain proteases | 17 | 3 |
Protein ubiquitination | 41 | 4 |
Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 6 | 3 |
Carboxyterminal post-translational modifications of tubulin | 7 | 9 |
Neddylation | 91 | 4 |
Post-translational protein phosphorylation | 2 | 2 |
Regulation of IGF Activity by IGFBP | 11 | 3 |
Unfolded Protein Response (UPR) | 85 | 2 |
IRE1alpha activates chaperones | 50 | 2 |
PERK regulates gene expression | 24 | 2 |
Surfactant metabolism | 16 | 11 |
Circadian Clock | 45 | 3 |
Disease | 1278 | 231 |
Diseases of signal transduction by growth factor receptors and second messengers | 262 | 31 |
Signaling by EGFR in Cancer | 12 | 4 |
Signaling by Ligand-Responsive EGFR Variants in Cancer | 11 | 4 |
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 11 | 4 |
Signaling by EGFRvIII in Cancer | 12 | 4 |
Constitutive Signaling by EGFRvIII | 12 | 4 |
Signaling by FGFR in disease | 33 | 5 |
Signaling by FGFR1 in disease | 23 | 4 |
FGFR1 mutant receptor activation | 19 | 2 |
Signaling by FGFR1 amplification mutants | 2 | 2 |
Signaling by activated point mutants of FGFR1 | 1 | 2 |
Signaling by cytosolic FGFR1 fusion mutants | 14 | 2 |
Signaling by plasma membrane FGFR1 fusions | 3 | 2 |
Signaling by FGFR2 in disease | 13 | 4 |
FGFR2 mutant receptor activation | 6 | 2 |
Activated point mutants of FGFR2 | 3 | 2 |
Signaling by FGFR2 amplification mutants | 2 | 2 |
Signaling by FGFR2 fusions | 1 | 2 |
Signaling by FGFR3 in disease | 10 | 4 |
Signaling by FGFR3 point mutants in cancer | 10 | 4 |
FGFR3 mutant receptor activation | 3 | 2 |
Signaling by activated point mutants of FGFR3 | 3 | 2 |
t(4;14) translocations of FGFR3 | 1 | 2 |
Signaling by FGFR3 fusions in cancer | 1 | 2 |
Signaling by FGFR4 in disease | 8 | 5 |
FGFR4 mutant receptor activation | 1 | 3 |
PI3K/AKT Signaling in Cancer | 18 | 3 |
Constitutive Signaling by Aberrant PI3K in Cancer | 2 | 2 |
Constitutive Signaling by AKT1 E17K in Cancer | 16 | 2 |
Signaling by NOTCH1 in Cancer | 19 | 3 |
Signaling by NOTCH1 PEST Domain Mutants in Cancer | 19 | 3 |
Constitutive Signaling by NOTCH1 PEST Domain Mutants | 19 | 3 |
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 19 | 3 |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 19 | 3 |
Signaling by TGF-beta Receptor Complex in Cancer | 6 | 1 |
Loss of Function of SMAD2/3 in Cancer | 5 | 1 |
SMAD2/3 Phosphorylation Motif Mutants in Cancer | 4 | 1 |
Loss of Function of TGFBR2 in Cancer | 2 | 1 |
TGFBR2 Kinase Domain Mutants in Cancer | 1 | 1 |
Signaling by WNT in cancer | 9 | 3 |
Signaling by CTNNB1 phospho-site mutants | 5 | 1 |
CTNNB1 S45 mutants aren't phosphorylated | 5 | 1 |
CTNNB1 T41 mutants aren't phosphorylated | 5 | 1 |
CTNNB1 S37 mutants aren't phosphorylated | 5 | 1 |
CTNNB1 S33 mutants aren't phosphorylated | 5 | 1 |
Hh mutants abrogate ligand secretion | 50 | 5 |
Hh mutants are degraded by ERAD | 49 | 5 |
Diseases associated with visual transduction | 7 | 10 |
Retinoid cycle disease events | 7 | 10 |
Oncogenic MAPK signaling | 36 | 5 |
Signaling by RAS mutants | 11 | 3 |
Signaling by high-kinase activity BRAF mutants | 4 | 2 |
Signaling by moderate kinase activity BRAF mutants | 10 | 3 |
Paradoxical activation of RAF signaling by kinase inactive BRAF | 10 | 3 |
Signaling by BRAF and RAF1 fusions | 28 | 2 |
Disorders of transmembrane transporters | 102 | 43 |
ABC transporter disorders | 57 | 10 |
Defective CFTR causes cystic fibrosis | 50 | 6 |
Defective ABCB4 causes PFIC3, ICP3 and GBD1 | 0 | 2 |
Defective ABCB6 causes MCOPCB7 | 0 | 3 |
Defective ABCB11 causes PFIC2 and BRIC2 | 0 | 2 |
Defective ABCA1 causes TGD | 1 | 3 |
Defective ABCA12 causes ARCI4B | 0 | 2 |
Defective ABCA3 causes SMDP3 | 0 | 2 |
Defective ABCC2 causes DJS | 0 | 2 |
Defective ABCC6 causes PXE | 1 | 2 |
Defective ABCC8 can cause hypo- and hyper-glycemias | 1 | 2 |
Defective ABCD1 causes ALD | 0 | 2 |
Defective ABCD4 causes MAHCJ | 2 | 3 |
Defective ABCG5 causes sitosterolemia | 1 | 2 |
Defective ABCG8 causes GBD4 and sitosterolemia | 1 | 2 |
SLC transporter disorders | 45 | 37 |
Defective GCK causes maturity-onset diabetes of the young 2 (MODY2) | 0 | 2 |
Defective HK1 causes hexokinase deficiency (HK deficiency) | 0 | 2 |
Diseases of metabolism | 69 | 121 |
Diseases of carbohydrate metabolism | 12 | 29 |
Essential fructosuria | 1 | 1 |
Defects in vitamin and cofactor metabolism | 17 | 17 |
Defects in cobalamin (B12) metabolism | 11 | 14 |
Defective MMAB causes MMA, cblB type | 0 | 2 |
Defects in biotin (Btn) metabolism | 6 | 4 |
Defective HLCS causes multiple carboxylase deficiency | 6 | 3 |
Metabolic disorders of biological oxidation enzymes | 6 | 47 |
Defective GCLC causes HAGGSD | 1 | 3 |
Defective GSS causes GSS deficiency | 0 | 4 |
Defective OPLAH causes OPLAHD | 0 | 3 |
Defective MAT1A causes MATD | 0 | 3 |
Diseases associated with surfactant metabolism | 5 | 4 |
Diseases of glycosylation | 22 | 43 |
Diseases associated with glycosaminoglycan metabolism | 5 | 13 |
Defective PAPSS2 causes SEMD-PA | 0 | 3 |
Diseases associated with glycosylation precursor biosynthesis | 6 | 21 |
Defective GALK1 causes GALCT2 | 0 | 2 |
Defective GNE causes sialuria, NK and IBM2 | 0 | 4 |
Infectious disease | 895 | 79 |
HIV Infection | 201 | 12 |
HIV Life Cycle | 130 | 10 |
Late Phase of HIV Life Cycle | 119 | 9 |
Transcription of the HIV genome | 63 | 4 |
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 10 | 2 |
HIV Transcription Elongation | 40 | 2 |
Tat-mediated elongation of the HIV-1 transcript | 28 | 2 |
Formation of HIV-1 elongation complex containing HIV-1 Tat | 28 | 2 |
Formation of HIV elongation complex in the absence of HIV Tat | 26 | 2 |
Uptake and actions of bacterial toxins | 38 | 9 |
Uptake and function of anthrax toxins | 12 | 6 |
Listeria monocytogenes entry into host cells | 12 | 4 |
InlA-mediated entry of Listeria monocytogenes into host cells | 6 | 4 |
InlB-mediated entry of Listeria monocytogenes into host cell | 6 | 2 |
Diseases of Immune System | 13 | 1 |
Defects in Toll-like Receptor Cascades | 13 | 1 |
IkBA variant leads to EDA-ID | 4 | 1 |
Neurodegenerative Diseases | 20 | 4 |
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | 20 | 4 |
Pervasive developmental disorders | 2 | 1 |
Loss of function of MECP2 in Rett syndrome | 2 | 1 |
Loss of phosphorylation of MECP2 at T308 | 0 | 1 |
DNA Replication | 119 | 11 |
DNA Replication Pre-Initiation | 95 | 3 |
Assembly of the pre-replicative complex | 78 | 2 |
Assembly of the ORC complex at the origin of replication | 8 | 2 |
Protein localization | 59 | 4 |
Mitochondrial protein import | 29 | 4 |
Peroxisomal protein import | 20 | 3 |
Chromatin organization | 120 | 16 |
Chromatin modifying enzymes | 120 | 16 |
RMTs methylate histone arginines | 18 | 4 |
Gene expression (Transcription) | 902 | 49 |
RNA Polymerase I Transcription | 41 | 4 |
RNA Polymerase I Promoter Clearance | 40 | 4 |
RNA Polymerase I Promoter Opening | 4 | 2 |
RNA Polymerase II Transcription | 728 | 42 |
Generic Transcription Pathway | 608 | 39 |
Transcriptional Regulation by TP53 | 219 | 31 |
TP53 Regulates Metabolic Genes | 43 | 24 |
TP53 Regulates Transcription of Cell Death Genes | 36 | 8 |
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 14 | 2 |
TP53 Regulates Transcription of Caspase Activators and Caspases | 12 | 2 |
TP53 Regulates Transcription of Cell Cycle Genes | 36 | 2 |
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | 17 | 2 |
TP53 Regulates Transcription of DNA Repair Genes | 24 | 2 |
Regulation of TP53 Activity | 99 | 10 |
Regulation of TP53 Expression and Degradation | 22 | 4 |
Regulation of TP53 Degradation | 21 | 4 |
Regulation of TP53 Activity through Phosphorylation | 49 | 3 |
Regulation of TP53 Activity through Association with Co-factors | 9 | 2 |
Regulation of TP53 Activity through Methylation | 15 | 4 |
Regulation of TP53 Activity through Acetylation | 20 | 7 |
PI5P Regulates TP53 Acetylation | 9 | 6 |
pseudouridine degradation | 0 | 8 |
superpathway of L-asparagine biosynthesis | 0 | 10 |
NADH repair | 0 | 8 |
4-hydroxybenzoate biosynthesis I (eukaryotes) | 0 | 18 |
inositol diphosphates biosynthesis | 0 | 8 |
glucose and glucose-1-phosphate degradation | 0 | 12 |
3-phosphoinositide biosynthesis | 0 | 8 |
L-asparagine biosynthesis II | 0 | 7 |
L-proline biosynthesis I | 0 | 13 |
Transcriptional regulation by RUNX1 | 121 | 6 |
L-methionine biosynthesis II | 0 | 17 |
L-proline biosynthesis I (from L-glutamate) | 0 | 13 |
Regulation of RUNX1 Expression and Activity | 7 | 4 |
trans-cinnamoyl-CoA biosynthesis | 0 | 8 |
mevalonate pathway I (eukaryotes and bacteria) | 0 | 17 |
S-adenosyl-L-methionine salvage II | 0 | 11 |
L-lysine biosynthesis I | 0 | 24 |
ethene biosynthesis I (plants) | 0 | 15 |
NAD(P)/NADPH interconversion | 0 | 11 |
adenosine deoxyribonucleotides de novo biosynthesis I | 0 | 5 |
RUNX1 regulates transcription of genes involved in differentiation of HSCs | 60 | 4 |
sedoheptulose bisphosphate bypass | 0 | 7 |
4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis I | 0 | 11 |
fatty acid u03B2-oxidation II (plant peroxisome) | 0 | 16 |
diphthamide biosynthesis II (eukaryotes) | 0 | 13 |
NADH repair (eukaryotes) | 0 | 8 |
acetyl-CoA biosynthesis from citrate | 0 | 7 |
ceramide degradation (generic) | 0 | 9 |
glycolysis IV | 0 | 19 |
coenzyme A biosynthesis I (bacteria) | 0 | 13 |
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | 11 | 2 |
5-aminoimidazole ribonucleotide biosynthesis II | 0 | 16 |
gluconeogenesis III | 0 | 24 |
Transcriptional regulation by RUNX2 | 106 | 4 |
Regulation of RUNX2 expression and activity | 68 | 2 |
RUNX2 regulates bone development | 25 | 2 |
RUNX2 regulates osteoblast differentiation | 18 | 2 |
acetate conversion to acetyl-CoA | 4 | 6 |
RUNX2 regulates genes involved in cell migration | 4 | 2 |
superpathway of proto- and siroheme biosynthesis | 16 | 38 |
pyrimidine deoxyribonucleotides de novo biosynthesis III | 6 | 21 |
superpathway of phosphatidylcholine biosynthesis | 8 | 18 |
Transcriptional regulation by RUNX3 | 78 | 7 |
sorbitol biosynthesis II | 0 | 10 |
[2Fe-2S] iron-sulfur cluster biosynthesis | 0 | 6 |
thiamine salvage IV (yeast) | 4 | 15 |
D-xylose degradation I | 2 | 6 |
Regulation of RUNX3 expression and activity | 49 | 2 |
thiamine salvage III | 1 | 5 |
superpathway of aspartate and asparagine biosynthesis | 4 | 12 |
simple coumarins biosynthesis | 22 | 21 |
benzoate degradation II (aerobic and anaerobic) | 3 | 6 |
Transcriptional Regulation by MECP2 | 38 | 2 |
Regulation of MECP2 expression and activity | 10 | 2 |
thiamine formation from pyrithiamine and oxythiamine (yeast) | 0 | 15 |
Transcriptional Regulation by E2F6 | 28 | 2 |
NAD/NADP-NADH/NADPH mitochondrial interconversion (yeast) | 0 | 10 |
RNA Polymerase II Transcription Initiation And Promoter Clearance | 43 | 5 |
RNA Polymerase II Promoter Escape | 43 | 3 |
RNA Pol II CTD phosphorylation and interaction with CE | 10 | 2 |
RNA Polymerase II Transcription Elongation | 51 | 2 |
Formation of RNA Pol II elongation complex | 39 | 2 |
RNA polymerase II transcribes snRNA genes | 62 | 7 |
TCA cycle III (animals) | 0 | 23 |
sucrose degradation V (sucrose u03B1-glucosidase) | 0 | 11 |
NAD salvage pathway II (PNC IV cycle) | 0 | 12 |
NAD phosphorylation and transhydrogenation | 0 | 7 |
Immune System | 914 | 82 |
Adaptive Immune System | 264 | 24 |
TCR signaling | 83 | 5 |
Phosphorylation of CD3 and TCR zeta chains | 6 | 4 |
Translocation of ZAP-70 to Immunological synapse | 5 | 4 |
Generation of second messenger molecules | 12 | 4 |
Downstream TCR signaling | 70 | 4 |
Costimulation by the CD28 family | 33 | 7 |
CD28 co-stimulation | 23 | 4 |
CD28 dependent PI3K/Akt signaling | 12 | 2 |
CD28 dependent Vav1 pathway | 9 | 4 |
CTLA4 inhibitory signaling | 2 | 4 |
PD-1 signaling | 4 | 3 |
B Cell Activation | 90 | 9 |
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | 24 | 5 |
Downstream signaling events of B Cell Receptor (BCR) | 66 | 7 |
Activation of NF-kappaB in B cells | 62 | 3 |
Activation of RAS in B cells | 0 | 4 |
CD22 mediated BCR regulation | 5 | 2 |
Class I MHC mediated antigen processing & presentation | 76 | 15 |
Antigen processing: Ubiquitination & Proteasome degradation | 46 | 4 |
4-deoxy-L-threo-hex-4-enopyranuronate degradation | 0 | 12 |
Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 14 | 7 |
L-rhamnose degradation I | 0 | 8 |
Antigen processing-Cross presentation | 67 | 9 |
ER-Phagosome pathway | 61 | 4 |
MHC class II antigen presentation | 24 | 7 |
Rap1 signalling | 2 | 7 |
Innate Immune System | 414 | 75 |
Toll-like Receptor Cascades | 101 | 8 |
Trafficking and processing of endosomal TLR | 7 | 3 |
Toll Like Receptor 10 (TLR10) Cascade | 50 | 4 |
MyD88 cascade initiated on plasma membrane | 49 | 4 |
IRAK1 recruits IKK complex | 7 | 2 |
IRAK2 mediated activation of TAK1 complex | 4 | 2 |
TAK1-dependent IKK and NF-kappa-B activation | 20 | 3 |
MAP kinase activation | 27 | 4 |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | 3 | 2 |
activated TAK1 mediates p38 MAPK activation | 3 | 2 |
carnosine biosynthesis | 0 | 7 |
ppGpp metabolism | 0 | 11 |
MAP3K8 (TPL2)-dependent MAPK1/3 activation | 10 | 2 |
lipoate salvage I | 0 | 6 |
diphthamide biosynthesis I (archaea) | 0 | 11 |
MAPK targets/ Nuclear events mediated by MAP kinases | 14 | 4 |
UMP biosynthesis III | 0 | 20 |
homocarnosine biosynthesis | 0 | 7 |
Activation of the AP-1 family of transcription factors | 5 | 2 |
Toll Like Receptor 3 (TLR3) Cascade | 53 | 4 |
TICAM1-dependent activation of IRF3/IRF7 | 6 | 2 |
TICAM1,TRAF6-dependent induction of TAK1 complex | 5 | 2 |
Toll Like Receptor 5 (TLR5) Cascade | 49 | 4 |
Toll Like Receptor 7/8 (TLR7/8) Cascade | 50 | 4 |
MyD88 dependent cascade initiated on endosome | 48 | 4 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 46 | 4 |
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | 7 | 2 |
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 4 | 2 |
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | 5 | 2 |
Toll Like Receptor 9 (TLR9) Cascade | 53 | 4 |
Toll Like Receptor 4 (TLR4) Cascade | 76 | 4 |
thiamine salvage II | 0 | 11 |
MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 52 | 4 |
xylitol degradation | 0 | 8 |
MyD88-independent TLR4 cascade | 56 | 4 |
TRIF(TICAM1)-mediated TLR4 signaling | 55 | 4 |
Activation of IRF3, IRF7 mediated by TBK1, IKBKE | 8 | 2 |
TRAF6-mediated induction of TAK1 complex within TLR4 complex | 7 | 2 |
Toll Like Receptor 2 (TLR2) Cascade | 57 | 4 |
Toll Like Receptor TLR1:TLR2 Cascade | 55 | 4 |
Toll Like Receptor TLR6:TLR2 Cascade | 56 | 4 |
sucrose degradation IV (sucrose phosphorylase) | 0 | 9 |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 33 | 5 |
NOD1/2 Signaling Pathway | 17 | 4 |
Inflammasomes | 16 | 3 |
The NLRP3 inflammasome | 13 | 2 |
The NLRP1 inflammasome | 1 | 2 |
DDX58/IFIH1-mediated induction of interferon-alpha/beta | 47 | 3 |
TRAF3-dependent IRF activation pathway | 11 | 2 |
TRAF6 mediated IRF7 activation | 5 | 2 |
TRAF6 mediated NF-kB activation | 7 | 2 |
Negative regulators of RIG-I/MDA5 signaling | 20 | 2 |
Cytosolic sensors of pathogen-associated DNA | 47 | 12 |
ZBP1(DAI) mediated induction of type I IFNs | 14 | 2 |
IRF3 mediated activation of type 1 IFN | 5 | 2 |
RIP-mediated NFkB activation via ZBP1 | 10 | 2 |
STING mediated induction of host immune responses | 16 | 6 |
IRF3-mediated induction of type I IFN | 13 | 4 |
STAT6-mediated induction of chemokines | 3 | 2 |
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | 3 | 2 |
Fcgamma receptor (FCGR) dependent phagocytosis | 32 | 11 |
FCGR activation | 5 | 2 |
Regulation of actin dynamics for phagocytic cup formation | 25 | 5 |
Role of phospholipids in phagocytosis | 4 | 9 |
DAP12 interactions | 28 | 4 |
DAP12 signaling | 10 | 4 |
Fc epsilon receptor (FCERI) signaling | 90 | 13 |
FCERI mediated MAPK activation | 17 | 4 |
FCERI mediated Ca+2 mobilization | 4 | 9 |
FCERI mediated NF-kB activation | 63 | 5 |
Role of LAT2/NTAL/LAB on calcium mobilization | 7 | 2 |
C-type lectin receptors (CLRs) | 88 | 17 |
CLEC7A (Dectin-1) signaling | 77 | 12 |
Dectin-1 mediated noncanonical NF-kB signaling | 54 | 2 |
Dectin-2 family | 9 | 3 |
CD209 (DC-SIGN) signaling | 7 | 7 |
Antimicrobial peptides | 38 | 18 |
Ion influx/efflux at host-pathogen interface | 4 | 6 |
UMP biosynthesis II | 0 | 20 |
Cytokine Signaling in Immune system | 495 | 11 |
Interferon Signaling | 141 | 7 |
Interferon alpha/beta signaling | 38 | 4 |
Interferon gamma signaling | 22 | 4 |
Antiviral mechanism by IFN-stimulated genes | 90 | 6 |
ISG15 antiviral mechanism | 40 | 3 |
OAS antiviral response | 10 | 5 |
Signaling by Interleukins | 294 | 4 |
Interleukin-1 family signaling | 109 | 3 |
Interleukin-1 signaling | 88 | 3 |
Interleukin-37 signaling | 8 | 2 |
Interleukin-38 signaling | 4 | 2 |
Interleukin-2 family signaling | 27 | 2 |
Interleukin-2 signaling | 9 | 2 |
Interleukin-9 signaling | 7 | 2 |
Interleukin-15 signaling | 10 | 2 |
Interleukin-21 signaling | 5 | 2 |
Interleukin receptor SHC signaling | 7 | 2 |
Interleukin-3, Interleukin-5 and GM-CSF signaling | 24 | 2 |
Regulation of signaling by CBL | 8 | 2 |
Interleukin-4 and Interleukin-13 signaling | 21 | 2 |
Interleukin-6 family signaling | 24 | 2 |
Interleukin-6 signaling | 10 | 2 |
Interleukin-7 signaling | 13 | 2 |
Interleukin-10 signaling | 7 | 2 |
Interleukin-12 family signaling | 56 | 2 |
Interleukin-12 signaling | 45 | 2 |
Interleukin-23 signaling | 9 | 2 |
Interleukin-27 signaling | 9 | 2 |
Interleukin-35 Signalling | 11 | 2 |
Interleukin-17 signaling | 36 | 4 |
Interleukin-20 family signaling | 17 | 2 |
Growth hormone receptor signaling | 7 | 4 |
Prolactin receptor signaling | 8 | 2 |
TNFR2 non-canonical NF-kB pathway | 87 | 2 |
NIK-->noncanonical NF-kB signaling | 53 | 2 |
Metabolism of RNA | 637 | 40 |
Processing of Capped Intron-Containing Pre-mRNA | 233 | 4 |
mRNA Splicing | 165 | 4 |
pre-mRNA splicing | 152 | 4 |
mRNA 3'-end processing | 46 | 1 |
Regulation of mRNA stability by proteins that bind AU-rich elements | 82 | 3 |
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 17 | 2 |
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 17 | 2 |
KSRP (KHSRP) binds and destabilizes mRNA | 15 | 3 |
HuR (ELAVL1) binds and stabilizes mRNA | 8 | 2 |
Nonsense-Mediated Decay (NMD) | 20 | 3 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 20 | 3 |
rRNA processing | 186 | 10 |
rRNA processing in the nucleus and cytosol | 176 | 8 |
rRNA modification in the nucleus and cytosol | 58 | 8 |
tRNA processing | 107 | 29 |
tRNA processing in the nucleus | 56 | 7 |
tRNA modification in the nucleus and cytosol | 43 | 25 |
tRNA processing in the mitochondrion | 5 | 3 |
Calvin-Benson-Bassham cycle | 13 | 21 |
wax esters biosynthesis II | 1 | 9 |
choline biosynthesis I | 2 | 21 |
superpathway of lipid-dependent phytate biosynthesis | 6 | 12 |
UMP biosynthesis I | 3 | 19 |
urea degradation I | 0 | 10 |
phosphatidylcholine biosynthesis I | 0 | 10 |
glycolysis IV (plant cytosol) | 13 | 47 |
C4 photosynthetic carbon assimilation cycle, NAD-ME type | 3 | 21 |
superpathway of L-citrulline metabolism | 6 | 29 |
phosphatidate metabolism, as a signaling molecule | 11 | 14 |
TCA cycle II (plants and fungi) | 14 | 19 |
superpathway of 1D-myo-inositol hexakisphosphate biosynthesis (plants) | 6 | 10 |
1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3) | 6 | 8 |
acetate and ATP formation from acetyl-CoA II | 0 | 6 |
UDP-u03B1-D-glucuronate biosynthesis (from myo-inositol) | 4 | 15 |
superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis | 10 | 34 |
superpathway of adenosine nucleotides de novo biosynthesis I | 6 | 14 |
indole-3-acetate inactivation VIII | 6 | 14 |
isoprene biosynthesis II (engineered) | 0 | 19 |
C4 photosynthetic carbon assimilation cycle, PEPCK type | 1 | 19 |
naringenin biosynthesis (engineered) | 3 | 14 |
trans-zeatin biosynthesis | 7 | 18 |
L-proline biosynthesis III | 1 | 15 |
UTP and CTP dephosphorylation I | 1 | 13 |
adlupulone and adhumulone biosynthesis | 4 | 16 |
UDP-u03B1-D-galacturonate biosynthesis II (from D-galacturonate) | 2 | 9 |
flavonoid di-C-glucosylation | 0 | 22 |
fructose 2,6-bisphosphate biosynthesis | 0 | 7 |
superpathway of pyrimidine ribonucleotides de novo biosynthesis | 6 | 22 |
1,4-dihydroxy-2-naphthoate biosynthesis II (plants) | 5 | 20 |
phosphatidate metabolism, as a signaling molecule (Chlamydomonas) | 0 | 9 |
glycerol degradation I | 1 | 7 |
L-histidine biosynthesis | 4 | 27 |
D-galactose degradation I (Leloir pathway) | 3 | 11 |
u03B3-glutamyl cycle | 6 | 14 |
phosphopantothenate biosynthesis II | 0 | 11 |
D-sorbitol biosynthesis I | 1 | 15 |
superpathway of thiamine diphosphate biosynthesis III (eukaryotes) | 3 | 24 |
cutin biosynthesis | 4 | 20 |
simplecoumarins biosynthesis | 6 | 20 |
L-lysine biosynthesis VI | 8 | 21 |
L-asparagine biosynthesis I | 0 | 9 |
superpathway of choline biosynthesis | 11 | 22 |
tetrahydroxyxanthone biosynthesis (from 3-hydroxybenzoate) | 0 | 21 |
methyl ketone biosynthesis (engineered) | 0 | 18 |
lipid IVA biosynthesis | 1 | 14 |
superpathway of purine nucleotides de novo biosynthesis I | 12 | 32 |
superpathway of tetrahydroxyxanthone biosynthesis | 0 | 26 |
indole-3-acetate inactivation III | 0 | 9 |
indole-3-acetate inactivation II | 0 | 8 |
superpathway of seleno-compound metabolism | 3 | 39 |
caffeoylglucarate biosynthesis | 2 | 10 |
superpathway of pyrimidine deoxyribonucleoside salvage | 6 | 19 |
glutathione biosynthesis | 2 | 9 |
u03B2-alanine biosynthesis II | 0 | 17 |
PRPP biosynthesis | 4 | 5 |
ethanol degradation II | 4 | 13 |
L-methionine degradation I (to L-homocysteine) | 2 | 11 |
salicortin biosynthesis | 0 | 17 |
L-arginine biosynthesis I (via L-ornithine) | 2 | 27 |
superpathway of phylloquinol biosynthesis | 17 | 31 |
ammonia assimilation cycle I | 2 | 13 |
L-methionine salvage cycle II (plants) | 8 | 29 |
phosphopantothenate biosynthesis I | 3 | 15 |
superpathway of coenzyme A biosynthesis II (plants) | 6 | 32 |
guanine and guanosine salvage III | 0 | 10 |
lupulone and humulone biosynthesis | 4 | 16 |
inosine-5'-phosphate biosynthesis II | 1 | 15 |
purine deoxyribonucleosides salvage | 4 | 11 |
L-selenocysteine biosynthesis II (archaea and eukaryotes) | 0 | 10 |
superpathway of sucrose and starch metabolism I (non-photosynthetic tissue) | 19 | 17 |
suberin monomers biosynthesis | 10 | 36 |
pyrimidine ribonucleosides salvage I | 2 | 9 |
L-arginine biosynthesis II (acetyl cycle) | 2 | 26 |
L-methionine salvage cycle I (bacteria and plants) | 2 | 32 |
NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde | 0 | 14 |
mannitol degradation II | 1 | 13 |
trehalose degradation II (cytosolic) | 6 | 8 |
curcuminoid biosynthesis | 4 | 19 |
purine nucleosides salvage II (plant) | 4 | 19 |
rosmarinic acid biosynthesis I | 1 | 30 |
hyperxanthone E biosynthesis | 1 | 24 |
folate transformations II | 7 | 21 |
L-citrulline biosynthesis | 6 | 21 |
cannabinoid biosynthesis | 1 | 22 |
L-methionine biosynthesis II (plants) | 3 | 17 |
C4 photosynthetic carbon assimilation cycle, NADP-ME type | 0 | 14 |
folate polyglutamylation | 5 | 9 |
acetyl-CoA biosynthesis III (from citrate) | 0 | 7 |
1D-myo-inositol hexakisphosphate biosynthesis I (from Ins(1,4,5)P3) | 0 | 8 |
adenosylcobalamin salvage from cobalamin | 0 | 4 |
selenate reduction | 1 | 15 |
D-myo-inositol (1,3,4)-trisphosphate biosynthesis | 1 | 8 |
benzoate biosynthesis I (CoA-dependent, u03B2-oxidative) | 1 | 19 |
acetate and ATP formation from acetyl-CoA I | 2 | 7 |
superpathway of cytosolic glycolysis (plants), pyruvate dehydrogenase and TCA cycle | 28 | 56 |
UDP-u03B2-L-arabinose biosynthesis II (from u03B2-L-arabinose) | 3 | 11 |
L-asparagine biosynthesis III (tRNA-dependent) | 1 | 11 |
stachyose degradation | 5 | 14 |
guanosine ribonucleotides de novo biosynthesis | 2 | 15 |
UTP and CTP dephosphorylation II | 1 | 11 |
pyridoxal 5'-phosphate salvage II (plants) | 3 | 19 |
mevalonate pathway I | 8 | 17 |
ppGpp biosynthesis | 0 | 11 |
S-adenosyl-L-methionine cycle II | 4 | 27 |
alkane biosynthesis II | 1 | 16 |
UDP-N-acetyl-D-glucosamine biosynthesis II | 9 | 16 |
adenosine deoxyribonucleotides de novo biosynthesis | 3 | 5 |
CMP phosphorylation | 0 | 5 |
glycolysis I (from glucose 6-phosphate) | 12 | 20 |
superpathway of acetyl-CoA biosynthesis | 1 | 12 |
superpathway of bitter acids biosynthesis | 5 | 25 |
GDP-glucose biosynthesis | 0 | 9 |
superpathway of L-lysine, L-threonine and L-methionine biosynthesis II | 11 | 33 |
L-leucine degradation I | 7 | 20 |
copper transport II | 4 | 6 |
ethanol degradation IV | 0 | 13 |
glutathione-mediated detoxification II | 8 | 16 |
1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza) | 7 | 11 |
pyrimidine deoxyribonucleosides salvage | 6 | 15 |
pyrimidine ribonucleotides interconversion | 4 | 16 |
L-arginine degradation V (arginine deiminase pathway) | 0 | 12 |
thiamine diphosphate biosynthesis IV (eukaryotes) | 2 | 11 |
superpathay of heme b biosynthesis from glutamate | 11 | 28 |
flavin biosynthesis I (bacteria and plants) | 5 | 21 |
2'-deoxymugineic acid phytosiderophore biosynthesis | 11 | 15 |
adenosine nucleotides degradation I | 3 | 27 |
D-galactose detoxification | 6 | 17 |
chorismate biosynthesis from 3-dehydroquinate | 0 | 14 |
5-aminoimidazole ribonucleotide biosynthesis I | 4 | 16 |
L-glutamine biosynthesis I | 2 | 7 |
L-homoserine biosynthesis | 2 | 11 |
protein NEDDylation | 0 | 4 |
phosphatidylcholine acyl editing | 0 | 11 |
coenzyme A biosynthesis I (prokaryotic) | 2 | 13 |
phosphatidylethanolamine biosynthesis II | 5 | 15 |
formate assimilation into 5,10-methylenetetrahydrofolate | 1 | 9 |
superpathway of indole-3-acetate conjugate biosynthesis | 8 | 28 |
superpathway of pyrimidine ribonucleosides salvage | 7 | 20 |
adenine and adenosine salvage VI | 0 | 5 |
crotonyl-CoA/ethylmalonyl-CoA/hydroxybutyryl-CoA cycle (engineered) | 0 | 27 |
biotin-carboxyl carrier protein assembly | 1 | 10 |
jasmonoyl-amino acid conjugates biosynthesis II | 0 | 10 |
sucrose degradation III (sucrose invertase) | 9 | 10 |
calmodulin regulated calcium transport | 1 | 6 |
GDP-L-fucose biosynthesis II (from L-fucose) | 0 | 8 |
tetrahydroxyxanthone biosynthesis (from benzoate) | 0 | 22 |
nitric oxide biosynthesis II (mammals) | 0 | 14 |
lysine degradation III | 2 | 22 |
saponin biosynthesis II | 0 | 13 |
long-chain fatty acid activation | 10 | 6 |
ornithine-citrulline shuttle | 2 | 12 |
NAD biosynthesis III (from nicotinamide) | 0 | 7 |
adenosine ribonucleotides de novo biosynthesis | 3 | 11 |
superpathway of phospholipid biosynthesis II (plants) | 17 | 31 |
coumarins biosynthesis (engineered) | 6 | 28 |
TCA cycle variation V (plant) | 14 | 22 |
L-threonine biosynthesis | 0 | 8 |
xanthohumol biosynthesis | 2 | 16 |
glutaminyl-tRNAgln biosynthesis via transamidation | 1 | 10 |
indole-3-acetate inactivation V | 6 | 7 |
starch biosynthesis | 14 | 21 |
u03B3-glutamyl cycle (plant pathway) | 3 | 12 |
tetrapyrrole biosynthesis I (from glutamate) | 5 | 19 |
superpathway of purines degradation in plants | 7 | 45 |
molybdenum cofactor biosynthesis | 6 | 18 |
photorespiration | 8 | 23 |
phenylpropanoid biosynthesis | 16 | 28 |
4-hydroxybenzoate biosynthesis III (plants) | 1 | 15 |
pyridoxal 5'-phosphate salvage I | 1 | 14 |
S-adenosyl-L-methionine biosynthesis | 1 | 6 |
superpathway of guanosine nucleotides de novo biosynthesis I | 4 | 6 |
6-gingerol analog biosynthesis (engineered) | 2 | 20 |
3,8-divinyl-chlorophyllide a biosynthesis I (aerobic, light-dependent) | 12 | 21 |
sucrose biosynthesis II | 15 | 18 |
pyruvate fermentation to (S)-lactate | 0 | 13 |
superpathway of rosmarinic acid biosynthesis | 1 | 40 |
UTP and CTP de novo biosynthesis | 3 | 11 |
pyrimidine deoxyribonucleotides de novo biosynthesis II | 0 | 17 |
NAD de novo biosynthesis I (from aspartate) | 5 | 22 |
NAD de novo biosynthesis II (from tryptophan) | 0 | 24 |
hydroxymethylpyrimidine salvage | 1 | 6 |
superpathway of pyrimidine nucleobases salvage | 5 | 14 |
superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) | 20 | 21 |
fatty acid biosynthesis (plant mitochondria) | 2 | 8 |
sphingolipid biosynthesis (plants) | 12 | 23 |
sucrose biosynthesis I (from photosynthesis) | 11 | 24 |
indole-3-acetate inactivation VII | 0 | 8 |
L-citrulline degradation | 1 | 10 |
superpathway of jasmonoyl-amino acid conjugates biosynthesis | 0 | 12 |
folate polyglutamylation II | 2 | 6 |
cinnamoyl-CoA biosynthesis | 0 | 8 |
homogalacturonan biosynthesis | 0 | 15 |
superpathway of tetrahydrofolate biosynthesis | 10 | 29 |
L-Nu03B4-acetylornithine biosynthesis | 5 | 20 |
3-amino-3-phenylpropanoyl-CoA biosynthesis | 1 | 7 |
urea cycle | 2 | 17 |
D-myo-inositol (1,4,5)-trisphosphate biosynthesis | 2 | 7 |
superpathway of pantothenate and coenzymeA biosynthesis | 5 | 23 |
tetrahydrofolate biosynthesis | 3 | 13 |
sulfate activation for sulfonation | 3 | 7 |
2-carboxy-1,4-naphthoquinol biosynthesis | 5 | 20 |
IAA biosynthesis VII | 2 | 8 |
pyruvate fermentation to acetate IV | 2 | 9 |
glycolysis II (from fructose 6-phosphate) | 13 | 20 |
S-methyl-5'-thioadenosine degradation I | 2 | 14 |
UDP-galactose biosynthesis (salvage pathway from galactose using UDP-glucose) | 0 | 18 |
copper transport I | 1 | 6 |
superpathway of L-isoleucine biosynthesis I | 4 | 26 |
ceramide degradation | 3 | 9 |
pyridine nucleotide cycling (plants) | 3 | 22 |
L-ornithine biosynthesis I | 1 | 17 |
cadmium transport I | 1 | 6 |
pyrimidine deoxyribonucleotides de novo biosynthesis I | 5 | 20 |
sporopollenin precursors biosynthesis | 4 | 26 |
tetrahydrofolate biosynthesis II | 12 | 32 |
D-myo-inositol-5-phosphate metabolism | 3 | 6 |
chorismate biosynthesis I | 4 | 18 |
gluconeogenesis I | 0 | 24 |
jasmonoyl-amino acid conjugates biosynthesis I | 1 | 11 |
superpathway of L-threonine biosynthesis | 2 | 17 |
ethylene biosynthesis I (plants) | 4 | 15 |
6-hydroxymethyl-dihydropterin diphosphate biosynthesis I | 4 | 17 |
indole-3-acetate inactivation IV | 6 | 9 |
NAD/NADH phosphorylation and dephosphorylation | 29 | 14 |
superpathway of glyoxylate cycle and fatty acid degradation | 25 | 29 |
lipid-dependent phytate biosynthesis I (via Ins(1,4,5)P3) | 2 | 8 |
phaselate biosynthesis | 3 | 14 |
D-sorbitol degradation I | 1 | 12 |
Rubisco shunt | 6 | 32 |
purine nucleotides degradation I (plants) | 3 | 34 |
superpathway of anaerobic sucrose degradation | 33 | 60 |
flavonoid biosynthesis | 8 | 19 |
guanosine deoxyribonucleotides de novo biosynthesis I | 4 | 6 |
homoglutathione biosynthesis | 2 | 9 |
starch degradation II | 6 | 10 |
jasmonic acid biosynthesis | 6 | 21 |
benzoate biosynthesis III (CoA-dependent, non-u03B2-oxidative) | 0 | 16 |
fatty acid u03B2-oxidation II (peroxisome) | 7 | 17 |
lipid-dependent phytate biosynthesis II (via Ins(1,3,4)P3) | 6 | 9 |
colupulone and cohumulone biosynthesis | 4 | 15 |
4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis | 2 | 11 |
coenzyme A biosynthesis II (eukaryotic) | 2 | 12 |
canavanine biosynthesis | 0 | 14 |
pyrimidine deoxyribonucleotide phosphorylation | 2 | 8 |
acridone alkaloid biosynthesis | 4 | 17 |
umbelliferone biosynthesis | 1 | 13 |
sucrose degradation II (sucrose synthase) | 17 | 22 |
indole-3-acetate inactivation VI | 0 | 7 |
tetrahydrofolate biosynthesis I | 0 | 13 |
Stat5 Activation | 1 | 2 |
Autophagy | 61 | 7 |
Selective autophagy | 36 | 4 |
Lipophagy | 2 | 3 |
Response of EIF2AK4 (GCN2) to amino acid deficiency | 13 | 2 |
Response of EIF2AK1 (HRI) to heme deficiency | 14 | 3 |
Aspartate and asparagine metabolism | 7 | 20 |
Glutamate and glutamine metabolism | 11 | 27 |
ALPK1 signaling pathway | 5 | 3 |
FLT3 Signaling | 26 | 7 |
Signaling by ERBB2 in Cancer | 16 | 10 |
Constitutive Signaling by Overexpressed ERBB2 | 8 | 4 |
Signaling by ERBB2 KD Mutants | 13 | 4 |
Signaling downstream of RAS mutants | 11 | 3 |
Diseases of programmed cell death | 36 | 11 |
EML4 and NUDC in mitotic spindle formation | 39 | 2 |
Sphingolipid metabolism (integrated pathway) | 11 | 67 |
Major receptors targeted by epinephrine and norepinephrine | 18 | 6 |
22q11.2 copy number variation syndrome | 2 | 28 |
Sphingolipid metabolism overview | 4 | 15 |
Sphingolipid metabolism: integrated pathway | 1 | 63 |
Purine metabolism | 13 | 36 |
nitrate reduction II (assimilatory) | 2 | 15 |
superpathway of fermentation (Chlamydomonas reinhardtii) | 7 | 17 |
Inorganic Nitrogen Assimilation | 4 | 14 |
assimilatory sulfate reduction II | 2 | 11 |
superpathway of ergosterol biosynthesis II | 1 | 33 |
ammonia assimilation cycle II | 3 | 8 |
superpathway of ammonia assimilation (plants) | 3 | 13 |
taxadiene biosynthesis (engineered) | 1 | 24 |
superpathway of geranylgeranyl diphosphate biosynthesis II (via MEP) | 19 | 23 |
pyruvate fermentation to acetate VII | 0 | 10 |
Organic Nitrogen Assimilation | 4 | 36 |
L-ornithine biosynthesis II | 2 | 15 |
oxalate degradation VI | 2 | 14 |
L-glutamine biosynthesis III | 7 | 25 |
ophthalmate biosynthesis | 0 | 10 |
methylerythritol phosphate pathway I | 0 | 20 |
glutamate-glutamine shuttle | 2 | 8 |
methylerythritol phosphate pathway II | 8 | 20 |
isoprene biosynthesis I | 1 | 22 |
reductive TCA cycle I | 0 | 25 |
oxygenic photosynthesis | 0 | 22 |
NAD salvage pathway V (PNC V cycle) | 0 | 17 |
thiamine diphosphate salvage IV (yeast) | 0 | 15 |
3,8-divinyl-chlorophyllide a biosynthesis III (aerobic, light independent) | 0 | 23 |
Sealing of the nuclear envelope (NE) by ESCRT-III | 13 | 7 |
Nervous system development | 337 | 13 |
Signaling by ERBB2 ECD mutants | 12 | 4 |
Signaling by ERBB2 TMD/JMD mutants | 12 | 4 |
Signaling by PDGFR in disease | 11 | 6 |
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 2 | 4 |
Signaling by PDGFRA extracellular domain mutants | 3 | 4 |
Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | 3 | 2 |
Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | 5 | 2 |
Leishmania infection | 66 | 26 |
Parasite infection | 23 | 5 |
Leishmania phagocytosis | 23 | 5 |
FCGR3A-mediated phagocytosis | 23 | 5 |
Killing mechanisms | 9 | 8 |
WNT5:FZD7-mediated leishmania damping | 9 | 8 |
Cell recruitment (pro-inflammatory response) | 18 | 7 |
Purinergic signaling in leishmaniasis infection | 18 | 7 |
Leishmania parasite growth and survival | 20 | 18 |
Anti-inflammatory response favouring Leishmania parasite infection | 20 | 18 |
CD163 mediating an anti-inflammatory response | 5 | 3 |
FCGR3A-mediated IL10 synthesis | 7 | 9 |
ADORA2B mediated anti-inflammatory cytokines production | 4 | 8 |
Diseases of the neuronal system | 7 | 10 |
Disorders of Developmental Biology | 2 | 1 |
NGF-stimulated transcription | 24 | 2 |
HMOX1 pathway (COVID-19 Disease Map) | 36 | 30 |
Signaling by RAF1 mutants | 2 | 3 |
Signaling by MAP2K mutants | 2 | 2 |
Signaling by KIT in disease | 5 | 7 |
Signaling by kinase domain mutants of KIT | 0 | 2 |
Signaling by juxtamembrane domain KIT mutants | 1 | 2 |
Signaling by extracellular domain mutants of KIT | 1 | 2 |
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | 4 | 4 |
SARS-CoV Infections | 282 | 29 |
SARS-CoV-1 Infection | 114 | 22 |
SARS-CoV-1 Genome Replication and Transcription | 6 | 8 |
Replication of the SARS-CoV-1 genome | 5 | 8 |
Transcription of SARS-CoV-1 sgRNAs | 2 | 7 |
Translation of Structural Proteins | 11 | 14 |
Maturation of nucleoprotein | 4 | 5 |
Potential therapeutics for SARS | 59 | 2 |
RAS processing | 13 | 18 |
SARS-CoV-1 Infection | 60 | 19 |
SARS-CoV-2 Infection | 77 | 20 |
Phosphoinositides metabolism | 49 | 6 |
Negative regulation of FLT3 | 11 | 5 |
FLT3 signaling in disease | 19 | 13 |
Signaling by FLT3 ITD and TKD mutants | 10 | 9 |
STAT5 activation downstream of FLT3 ITD mutants | 7 | 7 |
Signaling by FLT3 fusion proteins | 14 | 9 |
SARS-CoV-2 Infection | 195 | 27 |
SARS-CoV-2 Genome Replication and Transcription | 7 | 10 |
Replication of the SARS-CoV-2 genome | 5 | 9 |
Transcription of SARS-CoV-2 sgRNAs | 3 | 8 |
Disorders of Nervous System Development | 2 | 1 |
RHOBTB3 ATPase cycle | 1 | 4 |
Cellular response to chemical stress | 167 | 40 |
Cytoprotection by HMOX1 | 34 | 19 |
ROS sensing by NFE2L2 | 51 | 2 |
Regulation of BACH1 activity | 7 | 2 |
Cellular response to starvation | 35 | 8 |
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 | 185 | 20 |
RHO GTPase cycle | 28 | 6 |
RHOU GTPase cycle | 2 | 4 |
Sensory Perception | 215 | 68 |
Sensory processing of sound | 36 | 7 |
Sensory processing of sound by inner hair cells of the cochlea | 30 | 6 |
Sensory processing of sound by outer hair cells of the cochlea | 17 | 6 |
Signaling by CSF3 (G-CSF) | 21 | 3 |
Kallmann syndrome | 4 | 7 |
7q11.23 copy number variation syndrome | 2 | 13 |
Complement system in neuronal development and plasticity | 0 | 6 |
Signaling by ALK in cancer | 71 | 4 |
Signaling by ALK fusions and activated point mutants | 71 | 2 |
Nuclear events stimulated by ALK signaling in cancer | 27 | 2 |
Signaling by ALK | 19 | 7 |
Sensory perception of taste | 40 | 12 |
Sensory perception of sweet, bitter, and umami (glutamate) taste | 36 | 10 |
Sensory perception of salty taste | 4 | 2 |
Defective Intrinsic Pathway for Apoptosis | 21 | 4 |
GPR143 in melanocytes and retinal pigment epithelium cells | 7 | 13 |
Pentose phosphate pathway in senescent cells | 5 | 10 |
Drug ADME | 63 | 87 |
Azathioprine ADME | 16 | 26 |
Aspirin ADME | 8 | 22 |
APAP ADME | 17 | 30 |
GPER1 signaling | 5 | 7 |
Biosynthesis and turnover of 1-deoxy-sphingoid bases | 0 | 13 |
Creatine pathway | 1 | 16 |
Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution | 7 | 5 |
Early SARS-CoV-2 Infection Events | 28 | 11 |
Late SARS-CoV-2 Infection Events | 34 | 18 |
SARS-CoV-2-host interactions | 155 | 9 |
SARS-CoV-2 activates/modulates innate and adaptive immune responses | 85 | 8 |
SARS-CoV-2 targets host intracellular signalling and regulatory pathways | 12 | 3 |
KEAP1-NFE2L2 pathway | 112 | 12 |
Nuclear events mediated by NFE2L2 | 89 | 12 |
GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | 47 | 2 |
Uptake of dietary cobalamins into enterocytes | 6 | 4 |
Transport of RCbl within the body | 8 | 4 |
Cobalamin (Cbl) metabolism | 7 | 22 |
Hippocampal synaptogenesis and neurogenesis | 1 | 6 |
Ribavirin ADME | 9 | 16 |
Prednisone ADME | 7 | 10 |
SARS-CoV-1 activates/modulates innate immune responses | 41 | 4 |
Translation of Accessory Proteins | 4 | 2 |
Transcriptional Regulation by NPAS4 | 24 | 4 |
NPAS4 regulates expression of target genes | 19 | 2 |
NADP biosynthesis | 0 | 5 |
NADPH repair (eukaryotes) | 0 | 8 |
ATP biosynthesis | 0 | 5 |
D-mannose degradation II | 0 | 6 |
avenanthramide biosynthesis | 0 | 21 |
N6-L-threonylcarbamoyladenosine37-modified tRNA biosynthesis | 0 | 8 |
pyrimidine deoxyribonucleotides biosynthesis from CTP | 0 | 16 |
propanoyl CoA degradation I | 0 | 9 |
glycogen biosynthesis I (from ADP-D-Glucose) | 0 | 9 |
superpathway of heme b biosynthesis from glutamate | 0 | 22 |
glycolysis III (from glucose) | 0 | 18 |
homolactic fermentation | 0 | 19 |
NFE2L2 regulating anti-oxidant/detoxification enzymes | 16 | 7 |
Ciprofloxacin ADME | 5 | 13 |
Signaling by CSF1 (M-CSF) in myeloid cells | 24 | 6 |
Carnosine metabolism of glial cells | 0 | 9 |
Lactate shuttle in glial cells | 18 | 18 |
Bacterial Infection Pathways | 123 | 47 |
Viral Infection Pathways | 727 | 39 |
Parasitic Infection Pathways | 66 | 26 |
Cardiomyocyte signaling pathways converging on Titin | 0 | 6 |
8p23.1 copy number variation syndrome | 0 | 13 |
Disturbed pathways in Duchenne Muscular Dystrophy | 2 | 11 |
G1 phase | 2 | 2 |
G1/S transition | 32 | 2 |
Assembly of pre-replication complex | 13 | 2 |
S phase | 34 | 10 |
Synthesis of DNA | 34 | 10 |
DNA strand Elongation | 13 | 2 |
Metabolic Epileptic Disorders | 25 | 89 |
10q22q23 copy number variation | 0 | 14 |
15q25 copy number variation | 0 | 8 |
IFNG signaling activates MAPKs | 4 | 2 |
PKR-mediated signaling | 43 | 4 |
Glycosphingolipid biosynthesis | 13 | 16 |
Mitochondrial RNA degradation | 10 | 4 |
Maternal to zygotic transition (MZT) | 60 | 17 |
Replacement of protamines by nucleosomes in the male pronucleus | 10 | 6 |
Respiratory Syncytial Virus Infection Pathway | 89 | 15 |
Respiratory syncytial virus (RSV) genome replication, transcription and translation | 25 | 13 |
Respiratory syncytial virus genome transcription | 3 | 8 |
Maturation of hRSV A proteins | 22 | 8 |
RSV-host interactions | 69 | 4 |
Mitochondrial protein degradation | 12 | 5 |
Cellular response to mitochondrial stress | 9 | 3 |
Mitochondrial Protein Import (yeast) | 33 | 3 |
sucrose degradation | 7 | 11 |
gluconeogenesis | 24 | 25 |
5-aminoimidazole ribonucleotide biosynthesis | 3 | 16 |
NAD salvage | 4 | 7 |
NAD de novo biosynthesis | 12 | 33 |
superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle | 47 | 37 |
glutamine biosynthesis | 1 | 8 |
L-glutamine tRNA biosynthesis | 2 | 9 |
diphthamide biosynthesis | 1 | 11 |
fructose 2,6-bisphosphate synthesis | 5 | 7 |
acetyl-CoA biosynthesis from citrate | 1 | 7 |
mevalonate pathway | 10 | 25 |
glycerol degradation | 4 | 6 |
selenocysteine biosynthesis | 6 | 10 |
methionine salvage cycle III | 10 | 28 |
stearate biosynthesis | 13 | 17 |
sorbitol degradation I | 1 | 9 |
2-oxobutanoate degradation | 8 | 14 |
guanosine deoxyribonucleotides de novo biosynthesis | 11 | 6 |
fatty acid activation | 8 | 4 |
4-hydroxybenzoate biosynthesis | 1 | 19 |
oxidative ethanol degradation III | 7 | 15 |
leucine degradation | 12 | 21 |
inosine-5'-phosphate biosynthesis | 3 | 15 |
guanosine nucleotides de novo biosynthesis | 15 | 18 |
purine nucleotides de novo biosynthesis | 30 | 37 |
GDP-glucose biosynthesis II | 7 | 11 |
flavin biosynthesis | 2 | 7 |
coenzyme A biosynthesis | 6 | 13 |
proline biosynthesis | 3 | 12 |
BMP Signalling Pathway | 5 | 2 |
lipoate salvage | 1 | 6 |
thiamin salvage III | 1 | 5 |
superpathway of tryptophan utilization | 42 | 92 |
pyrimidine deoxyribonucleotides de novo biosynthesis | 15 | 18 |
protein neddylation | 6 | 4 |
ornithine de novo biosynthesis | 3 | 14 |
glycolysis | 25 | 19 |
arachidonate biosynthesis III (metazoa) | 16 | 19 |
TCA cycle | 17 | 24 |
propionyl-CoA degradation | 4 | 9 |
inositol pyrophosphates biosynthesis | 7 | 11 |
asparagine biosynthesis | 1 | 9 |
trehalose degradation | 5 | 9 |
cysteine biosynthesis | 5 | 19 |
pyridoxal 5'-phosphate salvage | 2 | 13 |
superpathway of methionine degradation | 19 | 45 |
methionine degradation | 4 | 10 |
icosapentaenoate biosynthesis II (metazoa) | 13 | 17 |
fatty acid u03B1-oxidation | 4 | 17 |
fatty acid u03B2-oxidation | 16 | 9 |
fatty acid u03B2-oxidation (peroxisome) | 15 | 12 |
UMP biosynthesis | 3 | 20 |
phosphatidylcholine biosynthesis | 6 | 11 |
u03B3-linolenate biosynthesis | 14 | 10 |
NAD biosynthesis III (from nicotinamide) | 3 | 10 |
sulfoquinovose degradation I | 4 | 10 |
NAD/NADP-NADH/NADPH mitochondrial interconversion (yeast) | 5 | 13 |
NAD/NADP-NADH/NADPH cytosolic interconversion (yeast) | 5 | 26 |
superpathway NAD/NADP - NADH/NADPH interconversion (yeast) | 10 | 31 |
pyridine nucleotide cycling (plants) | 0 | 22 |
NAD/NADH phosphorylation and dephosphorylation | 29 | 19 |
dissimilatory sulfate reduction I (to hydrogen sufide)) | 8 | 14 |
NAD phosphorylation and transhydrogenation | 5 | 10 |
NAD phosphorylation and dephosphorylation | 3 | 12 |
phytol degradation | 2 | 15 |
(S)-propane-1,2-diol degradation | 6 | 18 |
pyrimidine ribonucleosides degradation | 5 | 13 |
superpathway of glycol metabolism and degradation | 10 | 35 |
1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3) | 3 | 8 |
chitin biosynthesis | 16 | 40 |
1D-myo-inositol hexakisphosphate biosynthesis I (from Ins(1,4,5)P3) | 2 | 8 |
homogalacturonan biosynthesis | 0 | 14 |
L-homoserine biosynthesis | 6 | 27 |
superpathway of 1D-myo-inositol hexakisphosphate biosynthesis (plants) | 3 | 10 |
superpathway of seleno-compound metabolism | 7 | 44 |
superpathway of 5-aminoimidazole ribonucleotide biosynthesis | 6 | 36 |
L-homomethionine biosynthesis | 4 | 20 |
5-aminoimidazole ribonucleotide biosynthesis I | 12 | 38 |
1D-myo-inositol hexakisphosphate biosynthesis II (mammalian) | 15 | 15 |
5-aminoimidazole ribonucleotide biosynthesis II | 6 | 32 |
PRPP biosynthesis | 4 | 9 |
D-cycloserine biosynthesis | 6 | 23 |
1D-myo-inositol hexakisphosphate biosynthesis IV (Dictyostelium) | 1 | 11 |
1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza) | 2 | 11 |
3,8-divinyl-chlorophyllide a biosynthesis I (aerobic, light-dependent) | 19 | 24 |
UDP-N-acetylmuramoyl-pentapeptide biosynthesis II (lysine-containing) | 9 | 26 |
allantoin degradation IV (anaerobic) | 4 | 22 |
UDP-N-acetylmuramoyl-pentapeptide biosynthesis I (meso-diaminopimelate containing) | 17 | 38 |
superpathway of allantoin degradation in yeast | 4 | 15 |
UDP-N-acetylmuramoyl-pentapeptide biosynthesis III (meso-diaminopimelate containing) | 2 | 22 |
ammonia assimilation cycle I | 4 | 14 |
ammonia assimilation cycle III | 4 | 33 |
ammonia assimilation cycle II | 6 | 8 |
cytidine-5'-diphosphate-glycerol biosynthesis | 3 | 15 |
L-glutamine biosynthesis I | 7 | 25 |
superpathway of ammonia assimilation (plants) | 2 | 14 |
vancomycin resistance II | 7 | 13 |
protein Pupylation and dePupylation | 2 | 6 |
urea cycle | 6 | 33 |
vancomycin resistance I | 5 | 14 |
superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis | 22 | 57 |
protein SAMPylation and SAMP-mediated thiolation | 3 | 7 |
peptidoglycan biosynthesis V (u03B2-lactam resistance) | 1 | 38 |
peptidoglycan biosynthesis IV (Enterococcus faecium) | 3 | 36 |
pyruvate fermentation to propanoate II (acrylate pathway) | 7 | 20 |
acetyl-CoA biosynthesis III (from citrate) | 3 | 7 |
superpathway of acetyl-CoA biosynthesis | 2 | 12 |
L-glutamate degradation VII (to butanoate) | 10 | 36 |
N-acetylglucosamine degradation II | 7 | 13 |
acetyl-CoA fermentation to butanoate II | 5 | 18 |
superpathway of cytosolic glycolysis (plants), pyruvate dehydrogenase and TCA cycle | 24 | 59 |
methyl ketone biosynthesis (engineered) | 4 | 13 |
glyoxylate cycle | 13 | 36 |
isopropanol biosynthesis (engineered) | 5 | 28 |
nitrate reduction VI (assimilatory) | 5 | 18 |
formaldehyde oxidation I | 1 | 24 |
ethylmalonyl-CoA pathway | 12 | 28 |
nitrate reduction II (assimilatory) | 4 | 15 |
rosmarinic acid biosynthesis I | 3 | 34 |
superpathway of glyoxylate cycle and fatty acid degradation | 26 | 25 |
nitrate reduction V (assimilatory) | 4 | 26 |
superpathway of thiosulfate metabolism (Desulfovibrio sulfodismutans) | 0 | 10 |
NADH repair | 3 | 10 |
ADP-L-glycero-u03B2-D-manno-heptose biosynthesis | 4 | 16 |
N-acetylneuraminate and N-acetylmannosamine degradation II | 2 | 4 |
superpathway of glycolysis and the Entner-Doudoroff pathway | 23 | 58 |
N-acetylneuraminate and N-acetylmannosamine degradation I | 4 | 16 |
Rubisco shunt | 8 | 32 |
chitin degradation to ethanol | 13 | 17 |
cis-alkene biosynthesis | 4 | 10 |
anthranilate degradation II (aerobic) | 3 | 11 |
1,5-anhydrofructose degradation | 1 | 11 |
Kdo transfer to lipid IVA II | 1 | 9 |
Calvin-Benson-Bassham cycle | 13 | 24 |
hentriaconta-3,6,9,12,15,19,22,25,28-nonaene biosynthesis | 4 | 14 |
superpathway of glycolysis, pyruvate dehydrogenase, TCA, and glyoxylate bypass | 39 | 89 |
Kdo8N transfer to lipid IVA | 1 | 8 |
long chain fatty acid ester synthesis (engineered) | 2 | 12 |
superpathay of heme b biosynthesis from glutamate | 20 | 47 |
methylaspartate cycle | 10 | 35 |
sedoheptulose bisphosphate bypass | 2 | 7 |
anthranilate degradation III (anaerobic) | 2 | 8 |
phosphopantothenate biosynthesis I | 13 | 29 |
pyruvate fermentation to acetate and lactate I | 7 | 13 |
phosphopantothenate biosynthesis II | 0 | 12 |
pyruvate fermentation to acetate VI | 3 | 14 |
phosphopantothenate biosynthesis III (archaebacteria) | 2 | 16 |
pyruvate fermentation to acetate III | 2 | 9 |
anhydromuropeptides recycling II | 8 | 19 |
anhydromuropeptides recycling I | 13 | 48 |
pyruvate fermentation to acetate and alanine | 3 | 12 |
L-lysine biosynthesis V | 14 | 24 |
salicortin biosynthesis | 0 | 20 |
peptidoglycan cross-bridge biosynthesis II (E. faecium) | 2 | 11 |
L-lysine biosynthesis IV | 3 | 23 |
pyruvate fermentation to acetate VII | 2 | 10 |
L-lysine biosynthesis VI | 8 | 23 |
L-lysine biosynthesis II | 6 | 35 |
pyruvate fermentation to acetate IV | 5 | 17 |
L-lysine biosynthesis III | 4 | 20 |
L-lysine biosynthesis I | 16 | 63 |
pyruvate fermentation to acetate and lactate II | 6 | 25 |
(aminomethyl)phosphonate degradation | 12 | 31 |
spermidine biosynthesis II | 7 | 15 |
linoleate biosynthesis II (animals) | 0 | 10 |
CMP-N-acetylneuraminate biosynthesis I (eukaryotes) | 7 | 38 |
pyruvate fermentation to acetate I | 3 | 17 |
thiamine salvage IV (yeast) | 4 | 17 |
plasmalogen biosynthesis | 10 | 24 |
phosphatidate biosynthesis (yeast) | 9 | 19 |
D-myo-inositol-5-phosphate metabolism | 11 | 10 |
thiamine salvage III | 2 | 5 |
pyruvate fermentation to acetate V | 3 | 12 |
superpathway of inositol phosphate compounds | 6 | 25 |
pyruvate fermentation to acetate II | 6 | 11 |
phosphatidate metabolism, as a signaling molecule | 11 | 17 |
3-phosphoinositide biosynthesis | 29 | 19 |
thiamine salvage I | 2 | 16 |
acetone degradation II (to acetoacetate) | 3 | 16 |
sucrose biosynthesis II | 9 | 18 |
sphingosine and sphingosine-1-phosphate metabolism | 11 | 20 |
hydroxymethylpyrimidine salvage | 6 | 7 |
sucrose biosynthesis III | 1 | 15 |
ceramide degradation | 3 | 5 |
3-amino-4,7-dihydroxy-coumarin biosynthesis | 4 | 11 |
arachidonate biosynthesis III (6-desaturase, mammals) | 5 | 19 |
glycerol degradation I | 3 | 10 |
suberin monomers biosynthesis | 13 | 42 |
umbelliferone biosynthesis | 1 | 14 |
sporopollenin precursors biosynthesis | 7 | 33 |
coumarins biosynthesis (engineered) | 8 | 31 |
sphingolipid recycling and degradation (yeast) | 8 | 20 |
cyanophycin metabolism | 3 | 10 |
TCA cycle I (prokaryotic) | 17 | 41 |
phenolphthiocerol biosynthesis | 12 | 31 |
superpathway of choline biosynthesis | 5 | 32 |
(R)- and (S)-3-hydroxybutanoate biosynthesis (engineered) | 7 | 17 |
superpathway of demethylmenaquinol-6 biosynthesis I | 0 | 21 |
phosphatidylcholine acyl editing | 1 | 6 |
8-amino-7-oxononanoate biosynthesis III | 3 | 13 |
photosynthetic 3-hydroxybutanoate biosynthesis (engineered) | 63 | 73 |
TCA cycle II (plants and fungi) | 24 | 22 |
pyrimidine deoxyribonucleotides de novo biosynthesis II | 10 | 30 |
pyrimidine deoxyribonucleotides de novo biosynthesis I | 30 | 34 |
dimycocerosyl triglycosyl phenolphthiocerol biosynthesis | 10 | 17 |
TCA cycle III (animals) | 17 | 24 |
S-methyl-5'-thioadenosine degradation I | 4 | 17 |
u03B2-D-mannosyl phosphomycoketide biosynthesis | 1 | 12 |
superpathway of the 3-hydroxypropanoate cycle | 16 | 34 |
3-hydroxypropanoate cycle | 13 | 29 |
partial TCA cycle (obligate autotrophs) | 0 | 26 |
Lipid A-core biosynthesis (E. coli K-12) | 10 | 25 |
3-hydroxypropanoate/4-hydroxybutanate cycle | 18 | 40 |
chitin derivatives degradation | 3 | 21 |
L-arabinose degradation I | 3 | 10 |
reductive acetyl coenzyme A pathway I (homoacetogenic bacteria) | 13 | 22 |
pyrimidine deoxyribonucleotides biosynthesis from CTP | 14 | 17 |
biotin-carboxyl carrier protein assembly | 6 | 15 |
crotonyl-CoA/ethylmalonyl-CoA/hydroxybutyryl-CoA cycle (engineered) | 13 | 35 |
pyrimidine deoxyribonucleotide phosphorylation | 15 | 15 |
CO2 fixation into oxaloacetate (anaplerotic) | 4 | 15 |
dimycocerosyl phthiocerol biosynthesis | 3 | 11 |
phthiocerol biosynthesis | 13 | 20 |
cutin biosynthesis | 6 | 25 |
TCA cycle V (2-oxoglutarate:ferredoxin oxidoreductase) | 12 | 33 |
superpathway of L-phenylalanine biosynthesis | 16 | 65 |
superpathway of dimethylsulfoniopropanoate degradation | 6 | 16 |
formate assimilation into 5,10-methylenetetrahydrofolate | 4 | 9 |
wax esters biosynthesis II | 2 | 7 |
diphthamide biosynthesis II (eukaryotes) | 6 | 13 |
pyrimidine deoxyribonucleotides de novo biosynthesis IV | 2 | 16 |
superpathway of bitter acids biosynthesis | 5 | 32 |
diphthamide biosynthesis I (archaea) | 2 | 12 |
2-heptyl-3-hydroxy-4(1H)-quinolone biosynthesis | 3 | 19 |
aerobic respiration III (alternative oxidase pathway) | 39 | 15 |
aerobic respiration I (cytochrome c) | 50 | 15 |
UMP biosynthesis II | 7 | 24 |
pyrimidine deoxyribonucleotides de novo biosynthesis III | 11 | 30 |
2-methylcitrate cycle II | 3 | 15 |
UMP biosynthesis III | 10 | 23 |
2-methylcitrate cycle I | 12 | 19 |
methylthiolincosamide biosynthesis | 5 | 19 |
propanoyl CoA degradation I | 12 | 13 |
6-gingerol analog biosynthesis (engineered) | 4 | 20 |
superpathway of rosmarinic acid biosynthesis | 2 | 43 |
Entner-Doudoroff pathway II (non-phosphorylative) | 4 | 25 |
phenylacetate degradation I (aerobic) | 15 | 30 |
UMP biosynthesis I | 12 | 34 |
phenylacetate degradation II (anaerobic) | 0 | 15 |
D-galactarate degradation I | 5 | 30 |
ethanol degradation II | 4 | 16 |
superpathway of trimethylamine degradation | 12 | 24 |
isopropylamine degradation | 8 | 16 |
ethanol degradation III | 4 | 15 |
superpathway of ornithine degradation | 7 | 27 |
ethanol degradation IV | 4 | 15 |
molybdenum cofactor biosynthesis | 18 | 23 |
preQ0 biosynthesis | 7 | 23 |
ethanolamine utilization | 13 | 36 |
superpathway of L-lysine degradation | 33 | 112 |
4-hydroxy-2(1H)-quinolone biosynthesis | 5 | 15 |
superpathway of N-acetylglucosamine, N-acetylmannosamine and N-acetylneuraminate degradation | 9 | 24 |
superpathway of Clostridium acetobutylicum acidogenic and solventogenic fermentation | 18 | 55 |
dopamine degradation | 4 | 31 |
pyruvate fermentation to acetone | 5 | 29 |
L-lysine degradation V | 1 | 33 |
superpathway of fermentation (Chlamydomonas reinhardtii) | 9 | 17 |
benzoyl-CoA degradation III (anaerobic) | 7 | 19 |
(-)-microperfuranone biosynthesis | 0 | 7 |
3,8-divinyl-chlorophyllide a biosynthesis II (anaerobic) | 9 | 34 |
3,8-divinyl-chlorophyllide a biosynthesis III (aerobic, light independent) | 8 | 23 |
benzoyl-CoA degradation II (anaerobic) | 5 | 20 |
limonene degradation I (D-limonene) | 3 | 26 |
superpathway of Clostridium acetobutylicum acidogenic fermentation | 10 | 32 |
limonene degradation II (L-limonene) | 3 | 25 |
2-amino-3-hydroxycyclopent-2-enone biosynthesis | 2 | 14 |
assimilatory sulfate reduction I | 10 | 24 |
superpathway of Clostridium acetobutylicum solventogenic fermentation | 14 | 44 |
psilocybin biosynthesis | 0 | 16 |
assimilatory sulfate reduction II | 13 | 13 |
assimilatory sulfate reduction III | 3 | 11 |
trans-caffeate degradation (aerobic) | 3 | 11 |
pyruvate fermentation to butanoate | 8 | 24 |
ferulate degradation | 3 | 10 |
superpathway of sulfate assimilation and cysteine biosynthesis | 12 | 41 |
grixazone biosynthesis | 5 | 25 |
superpathway of quinolone and alkylquinolone biosynthesis | 7 | 24 |
4-coumarate degradation (aerobic) | 5 | 17 |
sulfoacetate degradation | 2 | 11 |
shinorine biosynthesis | 3 | 21 |
autoinducer AI-2 degradation | 4 | 9 |
5-hydroxymethylfurfural degradation | 8 | 21 |
3,3'-disulfanediyldipropannoate degradation | 5 | 17 |
3-amino-5-hydroxybenzoate biosynthesis | 3 | 24 |
tabtoxinine-u03B2-lactam biosynthesis | 3 | 12 |
fructoselysine and psicoselysine degradation | 3 | 13 |
gliotoxin biosynthesis | 7 | 29 |
4-deoxy-L-threo-hex-4-enopyranuronate degradation | 10 | 17 |
superpathway of microbial D-galacturonate and D-glucuronate degradation | 35 | 92 |
L-glutamate and L-glutamine biosynthesis | 14 | 42 |
adenosine nucleotides degradation I | 2 | 27 |
pseudouridine degradation | 2 | 9 |
2-oxobutanoate degradation I | 10 | 28 |
purine nucleotides degradation I (plants) | 2 | 34 |
purine nucleotides degradation II (aerobic) | 22 | 46 |
adenosylcobalamin biosynthesis from adenosylcobinamide-GDP II | 2 | 12 |
inosine 5'-phosphate degradation | 13 | 24 |
nucleoside and nucleotide degradation (archaea) | 7 | 22 |
flavin biosynthesis IV (mammalian) | 2 | 7 |
flavin biosynthesis I (bacteria and plants) | 17 | 26 |
flavin biosynthesis II (archaea) | 8 | 28 |
flavin biosynthesis III (fungi) | 8 | 23 |
phosphatidylcholine biosynthesis I | 8 | 16 |
furfural degradation | 5 | 17 |
L-cysteine biosynthesis II (tRNA-dependent) | 2 | 10 |
L-carnitine degradation III | 7 | 24 |
tRNA charging | 26 | 54 |
glutaminyl-tRNAgln biosynthesis via transamidation | 9 | 10 |
L-carnitine degradation I | 4 | 17 |
D-galactose detoxification | 5 | 23 |
atromentin biosynthesis | 3 | 8 |
glutathione-mediated detoxification II | 15 | 17 |
superpathway of sulfur metabolism (Desulfocapsa sulfoexigens) | 0 | 11 |
adenosine deoxyribonucleotides de novo biosynthesis | 10 | 5 |
superpathway of adenosine nucleotides de novo biosynthesis I | 24 | 24 |
trehalose degradation IV | 0 | 23 |
superpathway of purine nucleotides de novo biosynthesis I | 36 | 49 |
superpathway of guanosine nucleotides de novo biosynthesis I | 24 | 36 |
trehalose degradation I (low osmolarity) | 4 | 12 |
citronellol degradation | 1 | 12 |
cis-genanyl-CoA degradation | 4 | 21 |
trehalose degradation V | 2 | 13 |
L-alanine degradation II (to D-lactate) | 0 | 17 |
trehalose degradation II (cytosolic) | 6 | 21 |
methylthiopropanoate degradation I (cleavage) | 3 | 12 |
naphthalene degradation (anaerobic) | 5 | 14 |
reductive TCA cycle I | 3 | 27 |
UTP and CTP de novo biosynthesis | 13 | 21 |
4-hydroxybenzoate biosynthesis III (plants) | 1 | 16 |
incomplete reductive TCA cycle | 6 | 18 |
4-chlorobenzoate degradation | 4 | 16 |
acetate and ATP formation from acetyl-CoA I | 12 | 23 |
L-alanine fermentation to propanoate and acetate | 7 | 31 |
reductive TCA cycle II | 10 | 24 |
u03B3-linolenate biosynthesis II (animals) | 3 | 10 |
L-glutamate degradation V (via hydroxyglutarate) | 7 | 26 |
acetate and ATP formation from acetyl-CoA II | 2 | 6 |
L-lysine fermentation to acetate and butanoate | 8 | 57 |
Bifidobacterium shunt | 3 | 26 |
D-glucarate degradation I | 5 | 31 |
hexitol fermentation to lactate, formate, ethanol and acetate | 7 | 36 |
acetylene degradation | 1 | 21 |
anaerobic energy metabolism (invertebrates, mitochondrial) | 13 | 42 |
mixed acid fermentation | 32 | 76 |
ferrichrome biosynthesis | 1 | 17 |
ecdysteroid metabolism (arthropods) | 8 | 14 |
long-chain fatty acid activation | 8 | 4 |
alkane biosynthesis II | 1 | 14 |
fumiquinazoline D biosynthesis | 5 | 15 |
superpathway of anaerobic energy metabolism (invertebrates) | 16 | 60 |
enterobactin biosynthesis | 5 | 19 |
purine nucleobases degradation I (anaerobic) | 2 | 40 |
sulfate activation for sulfonation | 13 | 11 |
crotonate fermentation (to acetate and cyclohexane carboxylate) | 3 | 27 |
purine nucleobases degradation II (anaerobic) | 0 | 51 |
benzoate fermentation (to acetate and cyclohexane carboxylate) | 3 | 30 |
pyoverdine I biosynthesis | 7 | 23 |
anaerobic energy metabolism (invertebrates, cytosol) | 3 | 29 |
acridone alkaloid biosynthesis | 3 | 17 |
bisucaberin biosynthesis | 3 | 15 |
6-hydroxymethyl-dihydropterin diphosphate biosynthesis III (Chlamydia) | 4 | 14 |
6-hydroxymethyl-dihydropterin diphosphate biosynthesis IV (Plasmodium) | 1 | 10 |
5-N-acetylardeemin biosynthesis | 0 | 14 |
6-hydroxymethyl-dihydropterin diphosphate biosynthesis I | 6 | 26 |
fumitremorgin C biosynthesis | 5 | 18 |
4-oxopentanoate degradation | 6 | 22 |
viridicatin biosynthesis | 0 | 20 |
6-hydroxymethyl-dihydropterin diphosphate biosynthesis V (Pyrococcus) | 1 | 13 |
desferrioxamine B biosynthesis | 0 | 16 |
6-hydroxymethyl-dihydropterin diphosphate biosynthesis II (Methanocaldococcus) | 4 | 17 |
D-erythronate degradation I | 1 | 10 |
phosphatidylethanolamine biosynthesis II | 1 | 16 |
tetrahydrofolate biosynthesis | 7 | 42 |
superpathway of acetate utilization and formation | 4 | 15 |
superpathway of roquefortine, meleagrin and neoxaline biosynthesis | 0 | 22 |
superpathway of tetrahydrofolate biosynthesis | 19 | 65 |
roquefortine C biosynthesis | 0 | 13 |
acinetoferrin biosynthesis | 4 | 14 |
peramine biosynthesis | 1 | 10 |
acetate conversion to acetyl-CoA | 5 | 10 |
folate polyglutamylation | 4 | 20 |
oleandomycin activation/inactivation | 4 | 10 |
cyclohexane-1-carboxylate degradation (anaerobic) | 2 | 9 |
superpathway of demethylmenaquinol-8 biosynthesis I | 11 | 33 |
superpathway of tetrahydrofolate biosynthesis and salvage | 13 | 70 |
asperlicin E biosynthesis | 0 | 12 |
D-erythronate degradation II | 4 | 11 |
N10-formyl-tetrahydrofolate biosynthesis | 12 | 56 |
aniline degradation | 5 | 16 |
D-gluconate degradation | 2 | 5 |
ethylbenzene degradation (anaerobic) | 11 | 24 |
4'-methoxyviridicatin biosynthesis | 0 | 18 |
L-threonate degradation | 4 | 11 |
peptidoglycan biosynthesis III (mycobacteria) | 12 | 36 |
superpathway of N-acetylneuraminate degradation | 39 | 79 |
rhizobactin 1021 biosynthesis | 6 | 22 |
D-threonate degradation | 1 | 10 |
superpathway of coenzyme A biosynthesis I (bacteria) | 9 | 42 |
norspermidine biosynthesis | 7 | 25 |
peptidoglycan biosynthesis I (meso-diaminopimelate containing) | 11 | 42 |
creatine-phosphate biosynthesis | 4 | 7 |
trypanothione biosynthesis | 0 | 7 |
peptidoglycan biosynthesis II (staphylococci) | 20 | 44 |
achromobactin biosynthesis | 2 | 17 |
superpathway of polyamine biosynthesis III | 7 | 28 |
superpathway of geranylgeranyl diphosphate biosynthesis II (via MEP) | 26 | 39 |
glutathionylspermidine biosynthesis | 1 | 9 |
ectoine biosynthesis | 5 | 20 |
yersiniabactin biosynthesis | 4 | 15 |
methanofuran biosynthesis | 6 | 24 |
superpathway of arginine and polyamine biosynthesis | 18 | 101 |
[2Fe-2S] iron-sulfur cluster biosynthesis | 9 | 6 |
factor 430 biosynthesis | 6 | 20 |
L-leucine degradation I | 20 | 26 |
putrebactin biosynthesis | 4 | 16 |
tetrahydromonapterin biosynthesis | 3 | 22 |
superpathway of pyrimidine deoxyribonucleoside salvage | 22 | 22 |
phenylpropanoid biosynthesis | 12 | 29 |
taxadiene biosynthesis (engineered) | 11 | 38 |
glycerol degradation to butanol | 10 | 35 |
staphyloferrin A biosynthesis | 3 | 9 |
malonate decarboxylase activation | 2 | 6 |
superpathway of pyrimidine ribonucleosides salvage | 22 | 37 |
pyruvate fermentation to butanol II (engineered) | 6 | 15 |
superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) | 36 | 33 |
1,3-propanediol biosynthesis (engineered) | 15 | 35 |
citrate lyase activation | 4 | 12 |
phytol salvage pathway | 1 | 9 |
1-butanol autotrophic biosynthesis (engineered) | 49 | 38 |
pyrimidine ribonucleosides salvage I | 6 | 13 |
tetrahydromethanopterin biosynthesis | 9 | 38 |
pyruvate fermentation to butanol I | 11 | 25 |
S-adenosyl-L-methionine biosynthesis | 5 | 19 |
glucosylglycerol biosynthesis | 4 | 14 |
polyacyltrehalose biosynthesis | 3 | 14 |
vibriobactin biosynthesis | 6 | 18 |
FeMo cofactor biosynthesis | 6 | 14 |
inosine-5'-phosphate biosynthesis III | 3 | 17 |
CMP phosphorylation | 10 | 6 |
inosine-5'-phosphate biosynthesis I | 5 | 18 |
pseudomonine biosynthesis | 2 | 15 |
u03B3-glutamyl cycle | 12 | 19 |
inosine-5'-phosphate biosynthesis II | 8 | 18 |
coenzyme B biosynthesis | 3 | 31 |
aurachin RE biosynthesis | 6 | 18 |
guanosine ribonucleotides de novo biosynthesis | 15 | 35 |
aurachin A, B, C and D biosynthesis | 10 | 26 |
2'-deoxymugineic acid phytosiderophore biosynthesis | 12 | 14 |
nickel cofactor biosynthesis | 2 | 14 |
GDP-glucose biosynthesis | 10 | 11 |
adenosine ribonucleotides de novo biosynthesis | 6 | 17 |
actinomycin D biosynthesis | 5 | 19 |
guanine and guanosine salvage III | 1 | 15 |
blasticidin S biosynthesis | 9 | 25 |
folate transformations II | 5 | 21 |
superpathway of guanine and guanosine salvage | 6 | 21 |
superpathway of purine nucleotide salvage | 13 | 34 |
ferrichrome A biosynthesis | 5 | 20 |
folate transformations I | 22 | 41 |
GDP-L-fucose biosynthesis II (from L-fucose) | 0 | 9 |
(5R)-carbapenem carboxylate biosynthesis | 3 | 18 |
superpathway of pyrimidine nucleobases salvage | 11 | 26 |
roseoflavin biosynthesis | 1 | 19 |
prodigiosin biosynthesis | 10 | 29 |
alginate degradation | 2 | 14 |
aerobactin biosynthesis | 4 | 17 |
GDP-D-glycero-u03B1-D-manno-heptose biosynthesis | 4 | 12 |
pyrimidine deoxyribonucleosides salvage | 15 | 17 |
L-phenylalanine degradation IV (mammalian, via side chain) | 6 | 39 |
4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis (yeast) | 7 | 29 |
L-threonine biosynthesis | 4 | 17 |
cephamycin C biosynthesis | 2 | 16 |
6-methylpretetramide biosynthesis | 9 | 17 |
4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis | 6 | 14 |
glycine degradation (Stickland reaction) | 8 | 10 |
pyochelin biosynthesis | 3 | 14 |
thiamine triphosphate metabolism | 0 | 8 |
holomycin biosynthesis | 8 | 19 |
superpathway of thiamine diphosphate biosynthesis III (eukaryotes) | 12 | 25 |
alcaligin biosynthesis | 4 | 16 |
superpathway of rifamycin B biosynthesis | 13 | 54 |
thiamine formation from pyrithiamine and oxythiamine (yeast) | 3 | 17 |
nocardicin A biosynthesis | 6 | 19 |
ATP biosynthesis | 40 | 15 |
staphyloferrin B biosynthesis | 7 | 20 |
mycothiol biosynthesis | 5 | 20 |
superpathway of L-methionine biosynthesis (transsulfuration) | 9 | 59 |
thiocoraline biosynthesis | 4 | 15 |
superpathway of polybrominated aromatic compound biosynthesis | 8 | 31 |
desferrioxamine E biosynthesis | 4 | 16 |
glutathione biosynthesis | 6 | 17 |
pyoluteorin biosynthesis | 4 | 17 |
L-methionine biosynthesis II (plants) | 3 | 21 |
novobiocin biosynthesis | 17 | 41 |
brominated pyrroles biosynthesis | 4 | 14 |
superpathway of L-homoserine and L-methionine biosynthesis | 6 | 49 |
validamycin biosynthesis | 10 | 34 |
baumannoferrin biosynthesis | 6 | 20 |
L-methionine biosynthesis IV (archaea) | 4 | 16 |
fatty acid u03B2-oxidation II (peroxisome) | 9 | 12 |
superpathway of candicidin biosynthesis | 15 | 30 |
superpathway of L-methionine biosynthesis (by sulfhydrylation) | 19 | 55 |
fatty acid u03B1-oxidation II | 7 | 18 |
D-xylose degradation I | 2 | 10 |
gentamicin biosynthesis | 4 | 26 |
fatty acid u03B2-oxidation I | 23 | 16 |
formaldehyde assimilation II (assimilatory RuMP Cycle) | 0 | 23 |
formaldehyde assimilation III (dihydroxyacetone cycle) | 4 | 22 |
fatty acid u03B2-oxidation (peroxisome, yeast) | 4 | 13 |
formaldehyde assimilation I (serine pathway) | 9 | 44 |
dapdiamides biosynthesis | 8 | 31 |
starch degradation II | 6 | 8 |
bacimethrin and bacimethrin pyrophosphate biosynthesis | 4 | 14 |
fatty acid u03B1-oxidation III | 3 | 12 |
mevalonate pathway III (archaea) | 4 | 18 |
glycerol-3-phosphate shuttle | 4 | 10 |
superpathway of penicillin, cephalosporin and cephamycin biosynthesis | 11 | 69 |
mevalonate pathway I | 24 | 31 |
mevalonate pathway II (archaea) | 6 | 19 |
fatty acid u03B2-oxidation VI (peroxisome) | 14 | 12 |
deacetylcephalosporin C biosynthesis | 4 | 44 |
superpathway of tetracycline and oxytetracycline biosynthesis | 15 | 30 |
L-pyrrolysine biosynthesis | 3 | 13 |
streptomycin biosynthesis | 4 | 52 |
erythritol degradation II | 3 | 10 |
taurine biosynthesis II | 2 | 19 |
phosalacine biosynthesis | 20 | 49 |
erythritol degradation I | 5 | 12 |
myo-, chiro- and scyllo-inositol degradation | 9 | 21 |
gluconeogenesis III | 24 | 25 |
D-sorbitol degradation I | 5 | 12 |
gluconeogenesis I | 28 | 62 |
superpathway of hexitol degradation (bacteria) | 29 | 60 |
gluconeogenesis II (Methanobacterium thermoautotrophicum) | 15 | 42 |
D-altritol and galactitol degradation | 4 | 10 |
bacilysin biosynthesis | 6 | 20 |
glycogen degradation II | 12 | 15 |
myo-inositol degradation I | 9 | 21 |
xylitol degradation | 6 | 12 |
jadomycin biosynthesis | 11 | 27 |
glycogen degradation I | 8 | 50 |
ribitol degradation | 1 | 14 |
D-arabitol degradation | 0 | 8 |
D-threitol degradation | 3 | 10 |
penicillin G and penicillin V biosynthesis | 3 | 19 |
mannitol cycle | 3 | 15 |
arginomycin biosynthesis | 7 | 22 |
L-histidine biosynthesis | 18 | 33 |
adenine and adenosine salvage VI | 3 | 6 |
L-methionine salvage cycle I (bacteria and plants) | 19 | 38 |
galactitol degradation | 9 | 13 |
clavulanate biosynthesis | 5 | 25 |
L-methionine salvage cycle III | 10 | 29 |
L-threitol degradation | 4 | 11 |
adenine and adenosine salvage V | 4 | 17 |
L-methionine salvage cycle II (plants) | 8 | 32 |
rhizocticin A and B biosynthesis | 7 | 23 |
adenine and adenosine salvage II | 4 | 15 |
UDP-N-acetyl-D-glucosamine biosynthesis II | 23 | 33 |
lactose and galactose degradation I | 5 | 21 |
phosphinothricin tripeptide biosynthesis | 19 | 56 |
oxalate degradation VI | 4 | 14 |
purine deoxyribonucleosides salvage | 12 | 12 |
D-galactose degradation V (Leloir pathway) | 8 | 13 |
D-galactose degradation I (Leloir pathway) | 10 | 46 |
saframycin A biosynthesis | 6 | 18 |
polymyxin A biosynthesis | 3 | 10 |
rifamycin B biosynthesis | 9 | 30 |
isopenicillin N biosynthesis | 3 | 23 |
indolmycin biosynthesis | 8 | 30 |
salicylate degradation IV | 3 | 15 |
candicidin biosynthesis | 10 | 21 |
puromycin biosynthesis | 2 | 27 |
L-threonine degradation I | 7 | 15 |
echinomycin and triostin A biosynthesis | 6 | 18 |
L-arginine biosynthesis III (via N-acetyl-L-citrulline) | 2 | 28 |
L-arginine biosynthesis I (via L-ornithine) | 11 | 53 |
dehydrophos biosynthesis | 10 | 25 |
L-arginine biosynthesis IV (archaebacteria) | 6 | 20 |
L-arginine biosynthesis II (acetyl cycle) | 1 | 37 |
nitric oxide biosynthesis II (mammals) | 5 | 23 |
L-cysteine biosynthesis VI (from L-methionine) | 5 | 18 |
L-cysteine biosynthesis V (mycobacteria) | 2 | 10 |
superpathway of L-cysteine biosynthesis (mammalian) | 9 | 28 |
glyphosate degradation III | 7 | 18 |
jasmonic acid biosynthesis | 7 | 34 |
superpathway of ergosterol biosynthesis II | 1 | 35 |
superpathway of ergosterol biosynthesis I | 21 | 56 |
Escherichia coli serotype O9a O-antigen biosynthesis | 4 | 18 |
nitrogen fixation II (flavodoxin) | 10 | 12 |
nitrogen fixation I (ferredoxin) | 6 | 19 |
benzoate degradation II (aerobic and anaerobic) | 4 | 7 |
superpathway of sulfur amino acid biosynthesis (Saccharomyces cerevisiae) | 10 | 43 |
guanosine deoxyribonucleotides de novo biosynthesis I | 15 | 6 |
superpathway of L-lysine, L-threonine and L-methionine biosynthesis I | 19 | 94 |
superpathway of L-aspartate and L-asparagine biosynthesis | 7 | 30 |
icosapentaenoate biosynthesis III (8-desaturase, mammals) | 4 | 19 |
glycolate and glyoxylate degradation I | 7 | 26 |
icosapentaenoate biosynthesis II (6-desaturase, mammals) | 4 | 17 |
superpathway of cholesterol biosynthesis | 21 | 78 |
superpathway of L-lysine, L-threonine and L-methionine biosynthesis II | 8 | 35 |
superpathway of aromatic amino acid biosynthesis | 21 | 84 |
L-asparagine biosynthesis III (tRNA-dependent) | 4 | 10 |
L-asparagine biosynthesis II | 2 | 9 |
tetrahydroxyxanthone biosynthesis (from 3-hydroxybenzoate) | 0 | 23 |
Methanobacterium thermoautotrophicum biosynthetic metabolism | 22 | 79 |
superpathway of L-asparagine biosynthesis | 2 | 16 |
L-asparagine biosynthesis I | 2 | 26 |
choline biosynthesis I | 0 | 21 |
sulfite oxidation III | 9 | 9 |
superpathway of u03B2-D-glucuronosides degradation | 11 | 36 |
cob(II)yrinate a,c-diamide biosynthesis II (late cobalt incorporation) | 14 | 44 |
superpathway of L-citrulline metabolism | 18 | 52 |
cob(II)yrinate a,c-diamide biosynthesis I (early cobalt insertion) | 17 | 31 |
L-citrulline biosynthesis | 7 | 36 |
superpathway of cholesterol degradation II (cholesterol dehydrogenase) | 30 | 58 |
superpathway of cholesterol degradation I (cholesterol oxidase) | 17 | 55 |
cholesterol degradation to androstenedione I (cholesterol oxidase) | 19 | 31 |
cholesterol degradation to androstenedione II (cholesterol dehydrogenase) | 13 | 34 |
colupulone and cohumulone biosynthesis | 4 | 18 |
3-phenylpropanoate degradation | 1 | 24 |
superpathway of phenylethylamine degradation | 9 | 39 |
chorismate biosynthesis I | 15 | 59 |
chorismate biosynthesis from 3-dehydroquinate | 10 | 37 |
adlupulone and adhumulone biosynthesis | 4 | 18 |
methylamine degradation II | 9 | 17 |
chorismate biosynthesis II (archaea) | 9 | 30 |
tRNA splicing I | 7 | 12 |
cannabinoid biosynthesis | 3 | 25 |
glyoxylate assimilation | 11 | 31 |
tRNA-uridine 2-thiolation (thermophilic bacteria) | 5 | 9 |
tRNA-uridine 2-thiolation (mammalian mitochondria) | 5 | 12 |
lupulone and humulone biosynthesis | 4 | 18 |
N-methylpyrrolidone degradation | 4 | 15 |
N6-L-threonylcarbamoyladenosine37-modified tRNA biosynthesis | 4 | 7 |
superpathway of CMP-sialic acids biosynthesis | 14 | 60 |
glutathione-mediated detoxification I | 10 | 18 |
CMP-2-keto-3-deoxy-D-glycero-D-galacto-nononate biosynthesis | 4 | 19 |
tRNA-uridine 2-thiolation (yeast mitochondria) | 4 | 11 |
sucrose degradation II (sucrose synthase) | 13 | 20 |
homocarnosine biosynthesis | 1 | 7 |
tRNA-uridine 2-thiolation (bacteria) | 10 | 19 |
tRNA-uridine 2-thiolation (cytoplasmic) | 9 | 10 |
sucrose degradation V (sucrose u03B1-glucosidase) | 6 | 11 |
glycolysis II (from fructose 6-phosphate) | 21 | 49 |
L-citrulline degradation | 4 | 15 |
cell-surface glycoconjugate-linked phosphocholine biosynthesis | 3 | 11 |
glycolysis I (from glucose 6-phosphate) | 37 | 51 |
glycolysis V (Pyrococcus) | 7 | 30 |
glycolysis IV (plant cytosol) | 7 | 47 |
sucrose degradation IV (sucrose phosphorylase) | 2 | 9 |
glycolysis III (from glucose) | 37 | 25 |
L-ascorbate degradation II (bacterial, aerobic) | 4 | 19 |
sucrose degradation VII (sucrose 3-dehydrogenase) | 0 | 15 |
sucrose degradation III (sucrose invertase) | 8 | 9 |
L-rhamnose degradation I | 8 | 22 |
trans-zeatin biosynthesis | 7 | 21 |
sucrose degradation I (sucrose phosphotransferase) | 8 | 10 |
superpathway of bacteriochlorophyll a biosynthesis | 22 | 70 |
L-ornithine biosynthesis I | 6 | 34 |
pyruvate fermentation to lactate | 4 | 20 |
L-Nu03B4-acetylornithine biosynthesis | 6 | 20 |
bacteriochlorophyll b biosynthesis | 6 | 20 |
L-ornithine biosynthesis II | 7 | 17 |
bacteriochlorophyll a biosynthesis | 11 | 24 |
siroheme amide biosynthesis | 1 | 11 |
bile acids degradation | 9 | 40 |
glycogen biosynthesis III (from u03B1-maltose 1-phosphate) | 8 | 18 |
2-carboxy-1,4-naphthoquinol biosynthesis | 21 | 29 |
glycogen biosynthesis I (from ADP-D-Glucose) | 4 | 25 |
androstenedione degradation | 34 | 39 |
sitosterol degradation to androstenedione | 0 | 33 |
starch biosynthesis | 12 | 20 |
superpathway of testosterone and androsterone degradation | 11 | 36 |
superpathway of tetrahydroxyxanthone biosynthesis | 0 | 28 |
superpathway of L-tyrosine biosynthesis | 15 | 57 |
superpathway of menaquinol-11 biosynthesis | 0 | 24 |
L-selenocysteine biosynthesis II (archaea and eukaryotes) | 6 | 13 |
superpathway of L-threonine biosynthesis | 7 | 41 |
superpathway of menaquinol-6 biosynthesis I | 3 | 24 |
L-selenocysteine biosynthesis I (bacteria) | 3 | 14 |
superpathway of menaquinol-8 biosynthesis I | 10 | 36 |
superpathway of menaquinol-12 biosynthesis | 0 | 24 |
stearate biosynthesis I (animals and fungi) | 8 | 17 |
urea degradation I | 1 | 11 |
toluene degradation VI (anaerobic) | 18 | 38 |
superpathway of menaquinol-9 biosynthesis | 1 | 24 |
superpathway of menaquinol-13 biosynthesis | 0 | 24 |
superpathway of menaquinol-10 biosynthesis | 0 | 24 |
UDP-N-acetyl-D-galactosamine biosynthesis II | 7 | 24 |
thiamine salvage II | 9 | 28 |
putrescine degradation II | 4 | 15 |
superpathway of menaquinol-7 biosynthesis | 9 | 25 |
L-arginine degradation V (arginine deiminase pathway) | 6 | 19 |
methylphosphonate degradation I | 7 | 17 |
methylphosphonate degradation II | 1 | 16 |
L-arginine degradation (Stickland reaction) | 12 | 54 |
superpathway of L-arginine, putrescine, and 4-aminobutanoate degradation | 12 | 42 |
UDP-yelosamine biosynthesis | 2 | 14 |
superpathway of chorismate metabolism | 56 | 186 |
sucrose biosynthesis I (from photosynthesis) | 13 | 26 |
gallate degradation III (anaerobic) | 1 | 30 |
superpathway of L-arginine and L-ornithine degradation | 13 | 47 |
superpathway of D-glucarate and D-galactarate degradation | 6 | 37 |
L-glutamate degradation IV | 6 | 20 |
superpathway of pyrimidine ribonucleotides de novo biosynthesis | 23 | 45 |
superpathway of sulfide oxidation (phototrophic sulfur bacteria) | 16 | 9 |
superpathway of taurine degradation | 6 | 37 |
Entner-Doudoroff pathway I | 16 | 39 |
superpathway of fucose and rhamnose degradation | 11 | 41 |
Entner-Doudoroff pathway III (semi-phosphorylative) | 2 | 28 |
superpathway of coenzyme A biosynthesis II (plants) | 5 | 32 |
coenzyme A biosynthesis I (prokaryotic) | 3 | 15 |
coenzyme A biosynthesis II (eukaryotic) | 10 | 12 |
superpathway of coenzyme A biosynthesis III (mammals) | 6 | 13 |
jasmonoyl-amino acid conjugates biosynthesis I | 0 | 9 |
jasmonoyl-amino acid conjugates biosynthesis II | 1 | 8 |
methylerythritol phosphate pathway I | 9 | 34 |
methylerythritol phosphate pathway II | 10 | 27 |
isoprene biosynthesis II (engineered) | 8 | 21 |
UDP-u03B1-D-galacturonate biosynthesis II (from D-galacturonate) | 0 | 9 |
homolactic fermentation | 34 | 23 |
heterolactic fermentation | 7 | 37 |
L-proline biosynthesis I | 5 | 17 |
lipoate salvage I | 4 | 8 |
L-proline biosynthesis III | 2 | 16 |
glycerol and glycerophosphodiester degradation | 4 | 12 |
glycerol degradation II | 3 | 18 |
lipoate biosynthesis and incorporation II | 2 | 11 |
superpathway of glycerol degradation to 1,3-propanediol | 8 | 26 |
lipoate salvage II | 2 | 8 |
aspartate superpathway | 25 | 122 |
superpathway of phylloquinol biosynthesis | 16 | 36 |
thiamine diphosphate biosynthesis III (Staphylococcus) | 0 | 12 |
pentose phosphate pathway | 9 | 29 |
aminopropanol phosphate biosynthesis II | 3 | 28 |
thiamine diphosphate biosynthesis IV (eukaryotes) | 7 | 12 |
aminopropanol phosphate biosynthesis I | 3 | 8 |
thiamine diphosphate biosynthesis II (Bacillus) | 2 | 9 |
D-galacturonate degradation I | 5 | 27 |
D-galacturonate degradation II | 4 | 26 |
ketogluconate metabolism | 7 | 12 |
thiamine diphosphate biosynthesis I (E. coli) | 2 | 18 |
glucose degradation (oxidative) | 7 | 18 |
pentose phosphate pathway (oxidative branch) I | 8 | 11 |
D-fructuronate degradation | 8 | 29 |
D-galactonate degradation | 4 | 17 |
superpathway of S-adenosyl-L-methionine biosynthesis | 9 | 61 |
L-idonate degradation | 3 | 7 |
superpathway of hexuronide and hexuronate degradation | 8 | 38 |
UTP and CTP dephosphorylation II | 6 | 14 |
UDP-u03B1-D-glucuronate biosynthesis (from myo-inositol) | 5 | 15 |
creatinine degradation II | 3 | 27 |
UTP and CTP dephosphorylation I | 3 | 14 |
(4S)-carveol and (4S)-dihydrocarveol degradation | 2 | 31 |
(4R)-carveol and (4R)-dihydrocarveol degradation | 2 | 31 |
superpathway of demethylmenaquinol-9 biosynthesis | 4 | 21 |
pyridoxal 5'-phosphate salvage I | 5 | 19 |
inositol diphosphates biosynthesis | 7 | 11 |
D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis | 2 | 9 |
D-myo-inositol (1,4,5)-trisphosphate biosynthesis | 16 | 21 |
D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis | 3 | 9 |
superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism | 20 | 15 |
superpathway of L-tryptophan biosynthesis | 16 | 65 |
D-myo-inositol (1,3,4)-trisphosphate biosynthesis | 17 | 12 |
superpathway of jasmonoyl-amino acid conjugates biosynthesis | 1 | 10 |
indole-3-acetate inactivation VIII | 4 | 19 |
superpathway of purines degradation in plants | 6 | 45 |
indole-3-acetate inactivation V | 4 | 11 |
saponin biosynthesis II | 0 | 17 |
indole-3-acetate inactivation III | 0 | 12 |
superpathway of L-threonine metabolism | 21 | 72 |
superpathway of indole-3-acetate conjugate biosynthesis | 5 | 33 |
sphingolipid biosynthesis (plants) | 12 | 26 |
indole-3-acetate inactivation VI | 0 | 10 |
superpathway of phosphatidylcholine biosynthesis | 0 | 19 |
indole-3-acetate inactivation IV | 4 | 11 |
carnosine biosynthesis | 1 | 7 |
fructose 2,6-bisphosphate biosynthesis | 5 | 7 |
superpathway of fumitremorgin biosynthesis | 9 | 25 |
indole-3-acetate inactivation VII | 0 | 12 |
ppGpp biosynthesis | 5 | 23 |
flavonoid biosynthesis | 8 | 23 |
superpathway of anaerobic sucrose degradation | 26 | 61 |
flavonoid di-C-glucosylation | 0 | 29 |
indole-3-acetate inactivation II | 0 | 10 |
naringenin biosynthesis (engineered) | 4 | 15 |
D-arabinose degradation II | 0 | 12 |
D-arabinose degradation I | 4 | 19 |
fructose degradation | 1 | 8 |
2-O-u03B1-mannosyl-D-glycerate degradation | 3 | 8 |
L-lyxose degradation | 4 | 11 |
superpathway of glyoxylate bypass and TCA | 18 | 55 |
D-galactosamine and N-acetyl-D-galactosamine degradation | 5 | 12 |
N-acetyl-D-galactosamine degradation | 3 | 12 |
ribose phosphorylation | 2 | 10 |
superpathway of pyridoxal 5'-phosphate biosynthesis and salvage | 9 | 37 |
D-allose degradation | 3 | 8 |
isoprene degradation | 8 | 17 |
2-methylpropene degradation | 0 | 18 |
C4 photosynthetic carbon assimilation cycle, PEPCK type | 2 | 23 |
fucose degradation | 4 | 14 |
methyl tert-butyl ether degradation | 14 | 25 |
L-glucose degradation | 0 | 17 |
superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis | 46 | 62 |
photorespiration | 17 | 23 |
mannitol degradation II | 1 | 15 |
C4 photosynthetic carbon assimilation cycle, NADP-ME type | 0 | 19 |
3,6-anhydro-u03B1-L-galactopyranose degradation | 5 | 15 |
glucose and glucose-1-phosphate degradation | 4 | 34 |
superpathway of glucose and xylose degradation | 0 | 29 |
oxygenic photosynthesis | 71 | 28 |
superpathway of pentose and pentitol degradation | 46 | 61 |
squid bioluminescence | 0 | 12 |
firefly bioluminescence | 1 | 25 |
ergothioneine biosynthesis I (bacteria) | 5 | 22 |
5,6-dimethylbenzimidazole biosynthesis I (aerobic) | 3 | 11 |
tetrapyrrole biosynthesis I (from glutamate) | 12 | 37 |
sorbitol biosynthesis II | 2 | 11 |
superpathway of L-methionine salvage and degradation | 28 | 69 |
L-methionine degradation I (to L-homocysteine) | 8 | 18 |
ethylene biosynthesis V (engineered) | 78 | 42 |
ethylene biosynthesis I (plants) | 8 | 15 |
methanogenesis from dimethylamine | 2 | 6 |
L-isoleucine biosynthesis IV | 3 | 19 |
methyl-coenzyme M reduction to methane | 6 | 13 |
3-dehydroquinate biosynthesis II (archaea) | 6 | 23 |
superpathway of L-isoleucine biosynthesis I | 17 | 55 |
dissimilatory sulfate reduction II (to thiosulfate) | 0 | 15 |
methanogenesis from acetate | 5 | 26 |
L-isoleucine biosynthesis V | 0 | 12 |
S-adenosyl-L-methionine cycle I | 4 | 17 |
NAD salvage pathway I (PNC VI cycle) | 4 | 20 |
trans-cinnamoyl-CoA biosynthesis | 4 | 12 |
NAD salvage pathway II (PNC IV cycle) | 3 | 14 |
NAD de novo biosynthesis II (from tryptophan) | 18 | 35 |
terrequinone A biosynthesis | 4 | 18 |
protein O-mannosylation III (mammals, core M3) | 8 | 11 |
NAD de novo biosynthesis I (from aspartate) | 7 | 34 |
NAD salvage pathway IV (from nicotinamide riboside) | 8 | 8 |
superpathway of NAD biosynthesis in eukaryotes | 11 | 35 |
acetylaszonalenin biosynthesis | 3 | 15 |
NAD salvage pathway V (PNC V cycle) | 4 | 21 |
NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde | 8 | 16 |
CreCB Two-Component Signal Transduction System | 2 | 2 |
BasSR Two-Component Signal Transduction System | 2 | 2 |
QseBC Two-Component Signal Transduction System, quorum sensing related | 2 | 2 |
DpiBA Two-Component Signal Transduction System | 2 | 2 |
KdpDE Two-Component Signal Transduction System, potassium-dependent | 2 | 2 |
EvgSA Two-Component Signal Transduction System | 2 | 2 |
CusSR Two-Component Signal Transduction System | 2 | 2 |
PhoRB Two-Component Signal Transduction System, phosphate-dependent | 2 | 2 |
PRPP biosynthesis II | 2 | 8 |
ArcAB Two-Component Signal Transduction System, quinone dependent | 2 | 2 |
AtoSC Two-Component Signal Transduction System | 2 | 2 |
prenylated FMNH2 biosynthesis | 4 | 11 |
PhoQP Two-Component Signal Transduction System, magnesium-dependent | 2 | 2 |
HprSR Two-Component Signal Transduction System | 2 | 2 |
RstBA Two-Component Signal Transduction System | 2 | 2 |
galactose degradation I (Leloir pathway) | 5 | 26 |
UhpBA Two Component Signal Transduction System | 2 | 2 |
NarQ Two-Component Signal Transduction System, nitrate dependent | 3 | 2 |
CpxAR Two-Component Signal Transduction System | 2 | 2 |
BaeSR Two-Component Signal Transduction System | 2 | 2 |
BarA UvrY Two-Component Signal Transduction System | 2 | 2 |
DcuSR Two-Component Signal Transduction System, dicarboxylate-dependent | 2 | 2 |
ZraSR Two-Component Signal Transduction System | 2 | 2 |
YpdAB Two-Component Signal Transduction System | 2 | 2 |
salvage pathways of pyrimidine ribonucleotides | 9 | 36 |
RcsCDB Two-Component Signal Transduction System | 4 | 2 |
salvage pathways of pyrimidine deoxyribonucleotides | 4 | 32 |
NarX Two-Component Signal Transduction System, nitrate dependent | 3 | 2 |
iron-sulfur cluster biosynthesis | 6 | 7 |
glucose-6-phosphate biosynthesis | 5 | 5 |
superpathway of phenylalanine, tyrosine and tryptophan biosynthesis | 13 | 36 |
salvage pathways of adenine, hypoxanthine and their nucleosides | 8 | 16 |
methionine degradation I (to homocysteine) | 3 | 17 |
urea degradation | 1 | 11 |
de novo biosynthesis of pyrimidine ribonucleotides | 10 | 24 |
folate transformations | 12 | 19 |
histidine biosynthesis | 7 | 22 |
glycerol biosynthesis | 4 | 12 |
sulfate reduction I (assimilatory) | 5 | 18 |
arginine biosynthesis | 9 | 26 |
superpathway of thiamin diphosphate biosynthesis III (eukaryotes) | 25 | 41 |
chorismate biosynthesis | 4 | 16 |
mannose degradation | 3 | 6 |
superpathway of purine nucleosides salvage | 9 | 20 |
4-methyl-5(u03B2-hydroxyethyl)thiazole salvage | 1 | 10 |
superpathway NAD/NADP - NADH/NADPH interconversion | 11 | 29 |
thiamin salvage IV | 9 | 17 |
superpathway of ergosterol biosynthesis | 22 | 56 |
adenosine nucleotides de novo biosynthesis | 4 | 17 |
superpathway of glutathione metabolism (truncated u03B3-glutamyl cycle) | 3 | 13 |
thiamin triphosphate metabolism | 0 | 8 |
thiamin formation from pyrithiamine and oxythiamine | 3 | 17 |
folate interconversions | 13 | 17 |
tRNA splicing | 8 | 12 |
phosphopantothenate biosynthesis | 4 | 15 |
nicotinate riboside salvage pathway I | 1 | 5 |
nicotinamide riboside salvage pathway I | 3 | 7 |
NAD salvage pathway | 11 | 21 |
NAD/NADP-NADH/NADPH cytosolic interconversion | 6 | 26 |
NAD/NADP-NADH/NADPH mitochondrial interconversion | 7 | 13 |
threonine biosynthesis from homoserine | 2 | 8 |
sucrose degradation III | 7 | 9 |
phospholipid biosynthesis II (Kennedy pathway) | 2 | 9 |
pyridoxal 5'-phosphate salvage pathway | 4 | 14 |
superpathway phosphatidate biosynthesis (yeast) | 10 | 19 |
adenosine deoxyribonucleotides de novo biosynthesis I | 4 | 5 |
citrulline biosynthesis | 8 | 23 |
homoserine biosynthesis | 3 | 10 |
fatty acid oxidation (non-cyclic) | 9 | 13 |
4-amino-2-methyl-5-phosphomethylpyrimidine biosynthesis | 12 | 29 |
thiamin diphosphate biosynthesis IV (eukaryotes) | 7 | 12 |
phosphatidylinositol phosphate biosynthesis | 14 | 10 |
inositol phosphate biosynthesis | 5 | 13 |
sorbitol degradation | 4 | 9 |
phospholipid biosynthesis (Kennedy pathway) | 4 | 14 |
1D-myo-inositol hexakisphosphate biosynthesis I (from Ins(1,4,5)P3) | 2 | 8 |
1,4-dihydroxy-2-naphthoate biosynthesis II (plants) | 5 | 17 |
coenzyme A biosynthesis I | 1 | 13 |
superpathway of aspartate and asparagine biosynthesis | 5 | 12 |
cadmium transport I | 3 | 6 |
indole-3-acetate degradation IV | 12 | 11 |
pyrimidine ribonucleotides interconversion | 12 | 14 |
1,4-dihydroxy-2-naphthoate biosynthesis | 5 | 17 |
lipid-dependent phytate biosynthesis II (via Ins(1,3,4)P3) | 8 | 9 |
L-methionine biosynthesis II | 9 | 16 |
indole-3-acetate degradation V | 12 | 11 |
lipid-dependent phytate biosynthesis I (via Ins(1,4,5)P3) | 4 | 8 |
tetrahydrofolate biosynthesis II | 23 | 33 |
u03B3-glutamyl cycle (plant pathway) | 3 | 14 |
D-galactose degradation III | 4 | 19 |
folate polyglutamylation II | 4 | 7 |
UDP-L-arabinose biosynthesis II (from L-arabinose) | 2 | 8 |
purine nucleosides salvage II (plant) | 6 | 13 |
L-citrulline-nitric oxide cycle | 5 | 14 |
TCA cycle variation V (plant) | 23 | 25 |
UDP-D-galacturonate biosynthesis II (from D-galacturonate) | 2 | 9 |
NAD biosynthesis I (from aspartate) | 4 | 20 |
superpathway of proto- and siroheme biosynthesis | 16 | 40 |
indole-3-acetyl-amide conjugate biosynthesis | 12 | 19 |
sulfate reduction II (assimilatory) | 1 | 11 |
trehalose degradation II (trehalase) | 6 | 9 |
ornithine-citrulline shuttle | 5 | 13 |
simple coumarins biosynthesis | 28 | 23 |
glutamate-glutamine shuttle | 4 | 8 |
xylose degradation I | 2 | 6 |
PRPP biosynthesis I | 5 | 5 |
superpathway of sucrose and starch metabolism I (non-photosynthetic tissue) | 29 | 16 |
superpathway of lipid-dependent phytate biosynthesis | 8 | 12 |
L-homoserine and L-methionine biosynthesis | 10 | 26 |
adenosylcobalamin biosynthesis from cobyrinate a,c-diamide I | 6 | 26 |
acetate formation from acetyl-CoA II | 1 | 6 |
adenosylcobalamin salvage from cobinamide I | 4 | 19 |
adenosylcobalamin salvage from cobalamin | 1 | 4 |
superpathway of demethylmenaquinol-8 biosynthesis | 8 | 21 |
arginine biosynthesis II (acetyl cycle) | 0 | 26 |
glutamine biosynthesis I | 0 | 7 |
1,4-dihydroxy-2-naphthoate biosynthesis I | 0 | 17 |
UDP-N-acetylmuramoyl-pentapeptide biosynthesis I (meso-DAP-containing) | 0 | 20 |
thiamin diphosphate biosynthesis I (E. coli) | 0 | 9 |
superpathway of phenylalanine, tyrosine, and tryptophan biosynthesis | 0 | 38 |
acetyl-CoA fermentation to butyrate II | 0 | 16 |
NAD salvage pathway I | 0 | 18 |
glycolysis I (from glucose-6P) | 0 | 18 |
glycolysis II (from fructose-6P) | 0 | 17 |
superpathway of u03B2-D-glucuronide and D-glucuronate degradation | 0 | 14 |
Lipid A-core biosynthesis | 0 | 18 |
superpathway of tryptophan biosynthesis | 0 | 30 |
adenosylcobalamin biosynthesis from cobyrinate a,c-diamide II | 0 | 29 |
superpathway of tyrosine biosynthesis | 0 | 24 |
homoserine and methionine biosynthesis | 0 | 22 |
superpathway of methionine biosynthesis (transsulfuration) | 0 | 25 |
citrulline degradation | 0 | 9 |
superpathway of phenylalanine biosynthesis | 0 | 22 |
proline biosynthesis I | 0 | 12 |
thiamin salvage I | 0 | 6 |
proline biosynthesis III | 0 | 13 |
thiamin salvage II | 0 | 11 |
asparagine biosynthesis I | 0 | 9 |
superpathway of asparagine biosynthesis | 0 | 10 |
biotin biosynthesis from 8-amino-7-oxononanoate I | 0 | 13 |
pantothenate and coenzyme A biosynthesis I | 0 | 24 |
arginine biosynthesis IV (archaebacteria) | 0 | 20 |
anhydromuropeptides recycling | 0 | 26 |
arginine biosynthesis I (via L-ornithine) | 0 | 27 |
propionyl CoA degradation | 7 | 9 |
superpathay of heme biosynthesis from glutamate | 7 | 21 |
asparagine biosynthesis III (tRNA-dependent) | 3 | 11 |
L-glutamine biosynthesis II (tRNA-dependent) | 3 | 9 |
glucose and xylose degradation | 23 | 28 |
citrulline-nitric oxide cycle | 5 | 23 |
carnitine degradation I | 2 | 10 |
NAD phosphorylation and dephosphorylation I | 2 | 8 |
formylTHF biosynthesis | 11 | 26 |
formate reduction to 5,10-methylenetetrahydrofolate | 1 | 11 |
5-dehydro-4-deoxy-D-glucuronate degradation | 4 | 11 |
arginine degradation V (arginine deiminase pathway) | 4 | 10 |
superpathway of methionine biosynthesis (by sulfhydrylation) | 6 | 30 |
pantothenate and coenzyme A biosynthesis II | 4 | 34 |
sulfate reduction III (assimilatory) | 1 | 11 |
biotin biosynthesis from 8-amino-7-oxononanoate | 2 | 12 |
isoleucine biosynthesis IV | 3 | 19 |
myo-, chiro- and scillo-inositol degradation | 6 | 17 |
adenosine deoxyribonucleotides de novo biosynthesis II | 2 | 5 |
superpathway of purine nucleotides de novo biosynthesis II | 26 | 38 |
superpathway of guanosine nucleotides de novo biosynthesis II | 4 | 17 |
superpathway of adenosine nucleotides de novo biosynthesis II | 14 | 14 |
guanosine deoxyribonucleotides de novo biosynthesis II | 2 | 7 |
superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli) | 5 | 19 |
arginine, ornithine and proline interconversion | 7 | 25 |
gluconate degradation | 0 | 7 |
salvage pathways of purine and pyrimidine nucleotides | 0 | 30 |
coelichelin biosynthesis | 0 | 7 |
biotin biosynthesis III | 0 | 15 |
aspartate biosynthesis II | 0 | 10 |
superpathway of glycolysis and TCA variant VIII | 0 | 33 |
ethylmalonyl pathway | 0 | 21 |
pantothenate biosynthesis II | 0 | 16 |
fatty acid oxidation pathway I | 0 | 11 |
streptorubin B biosynthesis | 0 | 20 |
adenosylcobalamin biosynthesis II (aerobic) | 0 | 60 |
acetyl-CoA dissimilation | 0 | 7 |
aspartate threonine lysine biosynthesis superpathway | 0 | 29 |
leucine degradation IV | 0 | 23 |
transulfuration | 0 | 21 |
calcium-dependent antibiotic biosynthesis | 0 | 22 |
PhoPR two-component signal transduction pathway | 2 | 2 |
YdfHI two-component signal transduction system | 2 | 2 |
DegSU two-component signal transduction system | 2 | 2 |
WalKR two-component signal transduction system | 2 | 2 |
ComPA two-component signal transduction system | 2 | 2 |
DctSR two-component signal transduction system | 2 | 1 |
DesKR two-component signal transduction system | 2 | 2 |
LytST two-component signal transduction system | 2 | 2 |
BceSR two-component signal transduction system | 2 | 2 |
CssSR two-component signal transduction system | 2 | 2 |
GlnKL two-component signal transduction system | 2 | 2 |
LiaSR two-component signal transduction system | 2 | 2 |
NatKR two-component signal transduction system | 2 | 2 |
CitST two-component signal transduction system | 2 | 2 |
YxdKJ two-component signal transduction system | 2 | 2 |
ResED two-component signal transduction system | 2 | 2 |
calcium transport I | 0 | 6 |
chlorophyllide a biosynthesis I (aerobic, light-dependent) | 11 | 24 |
chlorophyllide a biosynthesis III (aerobic, light independent) | 13 | 24 |
L-ornithine biosynthesis | 5 | 17 |
SphS sensory histidine kinase | 2 | 2 |
NblS sensory histidine kinase | 2 | 2 |
circadian clock oscillator KaiABC | 1 | 2 |
SasA sensory histidine kinase | 2 | 2 |
adenosylcobalamin biosynthesis II (late cobalt incorporation) | 26 | 55 |
sulfoglycolysis | 4 | 10 |
galactosamine degradation | 8 | 11 |
N-acetyl-galactosamine degradation | 9 | 12 |
adenosylcobalamin salvage from cobinamide II | 0 | 21 |
molybdenum cofactor biosynthesis I | 0 | 13 |
7-keto-8-aminopelargonate biosynthesis II | 0 | 10 |
biotin biosynthesis from 7-keto-8-aminopelargonate | 0 | 12 |
UDP-N-acetylmuramoyl-pentapeptide biosynthesis I (generic) | 0 | 16 |
lysine biosynthesis II | 0 | 23 |
sucrose degradation IV | 0 | 9 |
L-1,2-propanediol degradation | 0 | 13 |
glycolysis III (glucokinase) | 0 | 17 |
acidification and chitin degradation (in carnivorous plants) | 0 | 5 |
3-hydroxypropionate/4-hydroxybutyrate cycle | 0 | 29 |
suberin biosynthesis | 0 | 29 |
galactose degradation IV | 0 | 13 |
phenylalanine degradation IV (mammalian, via side chain) | 0 | 26 |
stearate biosynthesis I (animals) | 0 | 17 |
heme biosynthesis I | 0 | 22 |
TCA cycle VI (obligate autotrophs) | 0 | 27 |
4-hydroxybenzoate biosynthesis V | 0 | 15 |
chlorophyllide a biosynthesis II | 0 | 23 |
thiamin diphosphate biosynthesis III (Staphylococcus) | 0 | 10 |
UDP-D-glucuronate biosynthesis (from myo-inositol) | 0 | 11 |
3-hydroxypropionate cycle | 0 | 24 |
glutamine biosynthesis III | 0 | 24 |
L-Nu03B4-acetylornithine biosynthesis | 0 | 15 |
thiamin diphosphate biosynthesis II (Bacillus) | 0 | 8 |
2'-(5'-phosphoribosyl)-3'-dephospho-CoA biosynthesis I (citrate lyase) | 0 | 6 |
nitrogen fixation | 0 | 7 |
chlorophyllide a biosynthesis III | 0 | 23 |
glutamate and glutamine biosynthesis | 0 | 12 |
lysine biosynthesis III | 8 | 18 |
glycolysis VI (metazoan) | 18 | 18 |
4-methyl-5(u03B2-hydroxyethyl)thiazole salvage (yeast) | 2 | 8 |
4-coumarate degradation | 4 | 14 |
aminomethylphosphonate degradation | 4 | 19 |
sulfate reduction V (dissimilatory, to thiosulfate) | 4 | 10 |
sulfate reduction IV (dissimilatory, to hydrogen sufide)) | 5 | 9 |
6-hydroxymethyl-dihydropterin diphosphate biosynthesis II (archaea) | 0 | 15 |
diphthamide biosynthesis (archaea) | 1 | 11 |
Poly(glycerol phosphate) wall teichoic acid biosynthesis | 0 | 12 |
Glycolysis and Gluconeogenesis | 0 | 8 |
Cori cycle | 1 | 21 |
Purine metabolism and related disorders | 23 | 53 |
Cysteine and methionine catabolism | 14 | 36 |
Effect of L-carnitine on metabolism | 0 | 9 |
Responses to stimuli: abiotic stimuli and stresses | 95 | 26 |
TCA cycle (plant) | 7 | 21 |
Citrulline-nitric oxide cycle | 2 | 14 |
Yang cycle | 2 | 17 |
SAM cycle | 1 | 11 |
Beta-alanine biosynthesis II | 1 | 18 |
Arginine biosynthesis | 5 | 26 |
Arginine biosynthesis II (acetyl cycle) | 4 | 25 |
Asparagine biosynthesis | 1 | 11 |
Asparagine biosynthesis III | 0 | 9 |
Canavanine biosynthesis | 1 | 10 |
Citrulline biosynthesis | 5 | 22 |
Glutamine biosynthesis I | 1 | 6 |
Histidine biosynthesis I | 7 | 21 |
Homoserine biosynthesis | 0 | 10 |
Lysine biosynthesis I | 2 | 24 |
Lysine biosynthesis II | 2 | 26 |
Lysine biosynthesis VI | 3 | 19 |
Methionine biosynthesis II | 0 | 17 |
Ornithine biosynthesis | 2 | 16 |
Proline biosynthesis I | 2 | 14 |
Threonine biosynthesis from homoserine | 0 | 7 |
shikimate pathway | 3 | 15 |
Allantoin degradation | 6 | 16 |
glycolysis IV | 1 | 19 |
glycolysis I | 4 | 18 |
Calvin cycle | 3 | 19 |
Starch biosynthesis | 0 | 9 |
GDP-mannose metabolism | 1 | 9 |
Peptidoglycan biosynthesis I | 1 | 21 |
UDP-D-GlcA biosynthesis | 3 | 9 |
UDP-L-arabinose biosynthesis and transport | 6 | 16 |
Galactose degradation II | 0 | 15 |
Mannose catabolism | 0 | 4 |
Trehalose degradation II | 1 | 7 |
Xylose catabolism | 1 | 6 |
Biotin biosynthesis II | 1 | 13 |
Flavin biosynthesis | 2 | 21 |
Folate polyglutamylation I | 1 | 12 |
Folate polyglutamylation II | 1 | 4 |
Gamma-glutamyl cycle | 1 | 11 |
Glutathione biosynthesis | 0 | 8 |
DXP pathway | 5 | 20 |
NAD biosynthesis I (from aspartate) | 4 | 19 |
Pantothenate and coenzyme A biosynthesis III | 1 | 19 |
Pantothenate biosynthesis I | 1 | 17 |
Pantothenate biosynthesis II | 1 | 17 |
vitamin K1 | 2 | 18 |
Pyridoxal 5'-phosphate salvage pathway | 1 | 12 |
Pyridoxamine anabolism | 1 | 7 |
Folate biosynthesis | 0 | 29 |
Tetrahydrofolate biosynthesis II | 1 | 28 |
Tetrapyrrole biosynthesis I | 5 | 14 |
Thiamin biosynthesis | 1 | 17 |
Reactive oxygen species (ROS) homeostasis | 1 | 11 |
Generation of superoxide radicals | 1 | 9 |
Trans-zeatin biosynthesis | 0 | 22 |
Jasmonic acid signaling | 1 | 6 |
ABA biosynthesis and mediated signaling | 3 | 15 |
Abscisic acid (ABA) mediated signaling | 2 | 4 |
Ethylene biosynthesis and signaling | 11 | 16 |
Ethene biosynthesis from methionine | 1 | 14 |
Ethylene mediated signaling | 10 | 4 |
Auxin transport | 1 | 6 |
Polar auxin transport | 1 | 6 |
Flavonoid biosynthesis | 1 | 19 |
Lipid-independent phytate biosynthesis | 5 | 12 |
MVA pathway | 1 | 16 |
Lignin biosynthesis | 2 | 21 |
Suberin biosynthesis | 0 | 22 |
Fatty acid activation | 0 | 4 |
Lipid-A-precursor biosynthesis | 3 | 13 |
Choline biosynthesis I | 0 | 14 |
Sphingolipid metabolism | 4 | 15 |
Glutamate synthase cycle | 3 | 10 |
Nitrate assimilation | 0 | 12 |
Sulfation pathway | 0 | 6 |
Response to iron deficiency | 10 | 17 |
Mugineic acid biosynthesis | 2 | 14 |
PRPP biosynthesis I | 0 | 4 |
PCO cycle | 8 | 24 |
Circadian rhythm | 17 | 2 |
Drosophila signaling pathways | 192 | 8 |
Circadian Clock pathway | 63 | 4 |
Phosphorylation of PER and TIM | 21 | 3 |
Transcription repression by PER and activation by PDP1 | 7 | 2 |
Hedgehog pathway | 71 | 4 |
N-HH ligand not bound to PTC receptor complex | 60 | 2 |
Assembly of the CI containing complexes | 20 | 2 |
Phosphorylation of CI | 19 | 2 |
N-HH ligand bound to PTC receptor complex | 63 | 2 |
Phosphorylation of SMO | 20 | 2 |
Activation of CI | 5 | 2 |
Hippo/Warts pathway | 18 | 2 |
DS ligand bound to FT receptor | 15 | 2 |
Subcellular localisation of D | 4 | 2 |
Formation of the Hippo kinase cassette | 4 | 2 |
Phosphorylation-dependent inhibition of YKI | 7 | 2 |
Imd pathway | 24 | 4 |
Activation of the IkappaB kinase complex, KEY:IRD5 dimer:KEY | 8 | 2 |
Catalytic processing of the nuclear factor, REL | 6 | 2 |
Activated IkappaB kinase (IKK) complex, Phospho IRD5:KEY dimer, phosphorylates REL in the PGN:PGRP-LC/LE receptor 'signalling complex' | 6 | 2 |
Formation of the cytosolic BSK 'scaffolding complex' | 4 | 3 |
Formation of the nuclear AP-1 transcription factor 'scaffolding complex' | 4 | 2 |
Insulin receptor mediated signaling | 16 | 5 |
Insulin signaling pathway | 8 | 3 |
TOR signaling pathway | 10 | 5 |
JAK/STAT pathway | 7 | 3 |
Formation of the activated receptor complex | 2 | 2 |
Formation of the activated STAT92E dimer and transport to the nucleus | 3 | 2 |
Planar Cell Polarity pathway | 34 | 5 |
Activation of Downstream Effectors | 31 | 5 |
RHO1 signalling | 23 | 5 |
Activation of non-muscle Myosin II | 13 | 3 |
Activation of RAC1:GTP by FZ:DSH complex | 9 | 3 |
JNK signalling | 6 | 3 |
Toll pathway | 47 | 2 |
Degradation of NF-kappa-B inhibitor, CACT | 42 | 2 |
Activated PLL kinase is autophosphorylated in the TL receptor 'signalling complex' | 5 | 2 |
DL and DIF homodimers complexed with CACT are all phosphorylated in the TL receptor 'signalling complex' | 6 | 2 |
Wingless pathway | 55 | 3 |
WG ligand not bound to FZ receptors | 49 | 2 |
Assembly of the 'destruction complex' | 8 | 2 |
Phosphorylation of AXN and APC | 7 | 2 |
Phosphorylation of ARM | 8 | 2 |
WG ligand bound to FZ receptors | 16 | 3 |
Assembly of receptor complex | 4 | 2 |
Phosphorylation of ARR | 4 | 2 |
DNA replication and repair | 53 | 15 |
DNA repair | 46 | 10 |
Chk1-controlled and DNA-damage induced centrosome duplication | 8 | 2 |
Double strand break repair | 22 | 2 |
Homologous recombination repair | 19 | 2 |
Homologous recombination repair of replication-dependent DSB | 7 | 2 |
Homologous recombination repair of replication-independent double-strand breaks | 16 | 2 |
ATM mediated response to DNA double-strand break | 10 | 2 |
ATM mediated phosphorylation of repair proteins | 8 | 2 |
Homologous DNA pairing and strand exchange | 5 | 2 |
Non-homologous end joining (NHEJ) | 3 | 2 |
Fanconi Anemia Pathway in DNA repair | 6 | 2 |
Glucose transport | 0 | 6 |
Lipid metabolism | 3 | 21 |
The tricarboxylic acid cycle | 4 | 22 |
Amino acid metabolism | 3 | 16 |
Arginine metabolism | 1 | 12 |
Pyrimidine metabolism: de novo synthesis of UMP | 2 | 21 |
Purine metabolism | 9 | 38 |
De novo synthesis of IMP | 5 | 26 |
De novo synthesis of GMP | 1 | 12 |
Toll-like receptors (TLR) cascades | 30 | 3 |
TLR2 subfamily cascade | 17 | 3 |
MyD88:TIRAP-dependent cascade initiated on plasma membrane | 14 | 3 |
NFkB and MAPK activation mediated by TRAF6 | 12 | 2 |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | 6 | 2 |
MAPK activation in TLR cascade | 4 | 2 |
Activated TAK1 mediates Jun kinases (JNK) phosphorylation and activation | 2 | 2 |
Activated TAK1 mediates p38 MAP kinase phosphorylation | 1 | 2 |
ERK activation | 2 | 2 |
TLR3 cascade | 16 | 2 |
IKK related kinases bound to dsRNA:TLR3:TICAM1 activate IRF3 | 3 | 2 |
Viral dsRNA:TLR3:TICAM1 Complex Activates TBK1 | 3 | 2 |
Viral dsRNA:TLR3:TICAM1 Complex Activates IKBKE_CHICK | 3 | 2 |
NFkB activation mediated by RIP1 complexed with activated TLR3 | 9 | 2 |
TRAF6 mediated induction of proinflammatory cytokines | 14 | 2 |
TLR4 cascade | 17 | 3 |
TLR5 cascade | 14 | 2 |
TLR7 cascade | 14 | 2 |
MyD88-dependent cascade initiated on endosome membrane | 13 | 2 |
NFkB and MAPK activation mediated by TRAF6 upon TLR7 or TLR21 stimulation | 13 | 2 |
TLR15 cascade | 14 | 2 |
TLR21 cascade | 14 | 2 |
RLR (RIG-like receptor) mediated induction of IFN alpha/beta | 16 | 2 |
TRAF mediated activation of IRF | 6 | 2 |